{"meta":{"query_hash":"f077d746d895","filters":{"venue":"Current Treatment Options in Oncology"},"cohort_total":60,"direct_labels_cover":0,"predictions_cover":60,"exported":60,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f077d746d895","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Treatment+Options+in+Oncology"},"results":[{"id":"W1972311575","doi":"10.1007/s11864-003-0010-2","title":"Therapeutic dilemmas in the management of uterine papillary serous carcinoma","year":2003,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Radiation therapy; Endometrial cancer; Regimen; Oncology; Internal medicine; Gynecologic oncology; Chemotherapy; Stage (stratigraphy); Cancer; Surgery","score_opus":0.19404959641388064,"score_gpt":0.46296769273399485,"score_spread":0.2689180963201142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972311575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013001164,0.9987429,0.000103829334,0.00033471672,0.00012440844,0.0000022782722,0.0000033559888,0.0000031162065,0.00055543915],"genre_scores_gemma":[0.0012007344,0.9976507,0.0002732227,0.00034267447,0.00027588787,0.000004279837,0.000010513965,0.0000010170537,0.00024096436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957246,0.00012247458,0.00007627536,0.00004790821,0.00015687896,0.000024015715],"domain_scores_gemma":[0.99917346,0.00051808375,0.00013536874,0.000013513805,0.00011821155,0.000041432813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012056609,0.0007017951,0.0020374854,0.002478447,0.00040721757,0.0013941752,0.0012532097,0.0015351204,0.0019796086],"category_scores_gemma":[0.0018246267,0.00029501307,0.00054382824,0.0022538474,0.0009501205,0.0016163952,0.0005715967,0.0019267356,0.0011310801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008316409,0.00006331842,0.00045837584,0.012888926,0.000086483065,0.0016881168,0.000120381366,0.0004242167,0.00072491606,0.0018667208,0.017140748,0.9644546],"study_design_scores_gemma":[0.00009387792,0.00022740774,0.0031331955,0.016011994,0.00049036805,0.023288095,0.0006653609,0.000442463,0.00067160855,0.004677269,0.9502296,0.00006872095],"about_ca_topic_score_codex":0.0014240885,"about_ca_topic_score_gemma":0.0043035564,"teacher_disagreement_score":0.002478447,"about_ca_system_score_codex":0.0007869397,"about_ca_system_score_gemma":0.0012133718,"threshold_uncertainty_score":0.0066224933},"labels":[],"label_agreement":null},{"id":"W1976333691","doi":"10.1007/s11864-011-0170-4","title":"How Do I Deal With the Axilla in Patients With a Positive Sentinel Lymph Node?","year":2011,"lang":"en","type":"article","venue":"Current Treatment Options in Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital; Cancer Care South East","funders":"","keywords":"Medicine; Axilla; Radiation therapy; Sentinel node; Breast cancer; Surgery; Axillary Lymph Node Dissection; Dissection (medical); Radiology; Sentinel lymph node; Oncology; Internal medicine; Cancer","score_opus":0.019958055427079277,"score_gpt":0.27174749905477225,"score_spread":0.25178944362769295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976333691","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22086419,0.15877537,0.0053581283,0.5402917,0.013779395,0.00021976526,0.00037437744,0.0001408898,0.06019618],"genre_scores_gemma":[0.6964278,0.1317542,0.015422849,0.12964608,0.0151506895,0.00026166684,0.0003243219,0.00009900281,0.010913407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995759,0.00017041132,0.000040276696,0.000041162646,0.00009006091,0.000082097955],"domain_scores_gemma":[0.99787927,0.0010118564,0.00036949408,0.00007348516,0.00028297314,0.00038295885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016803682,0.00021712128,0.0005617975,0.00035112866,0.00087711634,0.0015265747,0.00046576947,0.002006605,0.005285298],"category_scores_gemma":[0.009903598,0.00016403398,0.000479078,0.00035250836,0.0010341987,0.0022657188,0.0004396935,0.002324289,0.0016752596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013139315,0.0008482542,0.21560383,0.0016328003,0.0002583501,0.0035338448,0.00220995,0.00042577367,0.0030138467,0.0024760996,0.08804469,0.6806386],"study_design_scores_gemma":[0.0012267694,0.005448146,0.37723228,0.012939603,0.0016295697,0.05680877,0.048351917,0.0016827744,0.009025721,0.033352517,0.45191106,0.00039093022],"about_ca_topic_score_codex":0.002430855,"about_ca_topic_score_gemma":0.005172069,"teacher_disagreement_score":0.005285298,"about_ca_system_score_codex":0.000462416,"about_ca_system_score_gemma":0.0016005673,"threshold_uncertainty_score":0.017681062},"labels":[],"label_agreement":null},{"id":"W1981857209","doi":"10.1007/s11864-007-0037-x","title":"Novel Therapies Targeting the Apoptosis Pathway for the Treatment of Acute Myeloid Leukemia","year":2007,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"XIAP; Medicine; Myeloid leukemia; Apoptosis; Cancer research; Leukemia; Inhibitor of apoptosis; Caspase; Programmed cell death; Immunology; Bioinformatics; Biology","score_opus":0.08527216299490954,"score_gpt":0.38885552095560605,"score_spread":0.3035833579606965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981857209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002313365,0.9969988,0.00055844506,0.0004509288,0.00039870286,0.000011203502,0.000016710243,0.000016630911,0.0013173046],"genre_scores_gemma":[0.0010196393,0.9962224,0.0007227954,0.0003533341,0.00023379261,0.000016180162,0.000046577916,0.0000026564478,0.0013826132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998355,0.00002237757,0.000016305527,0.000023588069,0.00008071394,0.000021507127],"domain_scores_gemma":[0.99978215,0.00009164746,0.000029858324,0.000006611707,0.00006305726,0.000026659412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059331383,0.0010366258,0.0019788023,0.0015870936,0.00037491016,0.00084351155,0.0013839258,0.0011386843,0.003409613],"category_scores_gemma":[0.00043842132,0.0002562174,0.0004767599,0.0015900044,0.00063556724,0.0010667416,0.0005914447,0.0028371734,0.0024998279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001222656,0.00012964896,0.000075474134,0.0037624897,0.00005787896,0.00025143728,0.000026816444,0.00040208577,0.0033704666,0.0028165884,0.03249348,0.9564915],"study_design_scores_gemma":[0.00011896344,0.00019969612,0.0006511169,0.0011339533,0.00011451682,0.0020813714,0.00003867695,0.00021842655,0.0017466452,0.0023893751,0.9912828,0.00002444709],"about_ca_topic_score_codex":0.00093248585,"about_ca_topic_score_gemma":0.002710665,"teacher_disagreement_score":0.003409613,"about_ca_system_score_codex":0.0007086729,"about_ca_system_score_gemma":0.0007700352,"threshold_uncertainty_score":0.011406302},"labels":[],"label_agreement":null},{"id":"W1984083792","doi":"10.1007/s11864-012-0181-9","title":"Patients With Metastatic Breast Cancer Using Bevacizumab as a Treatment: Is There Still a Role for it?","year":2012,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Clinical trial; Angiogenesis; Internal medicine; Cancer; Vascular endothelial growth factor; Biomarker; Chemotherapy; Colorectal cancer; Paclitaxel; Metastasis; VEGF receptors","score_opus":0.19670101289944478,"score_gpt":0.50025470231862,"score_spread":0.30355368941917527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984083792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018631388,0.998218,0.000085064625,0.0006150475,0.00012118357,0.000002838626,0.000011424226,0.000004523268,0.0007554654],"genre_scores_gemma":[0.0014834022,0.9969722,0.00022345313,0.0005803588,0.00020217594,0.0000064293913,0.000025993013,0.0000011581644,0.0005048023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998529,0.000036523023,0.000024309864,0.000024980993,0.000045095952,0.000016210533],"domain_scores_gemma":[0.9996892,0.0001587787,0.00007246687,0.000005446571,0.000049396203,0.000024722764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005234508,0.0005014419,0.0014841231,0.00091568835,0.00017469318,0.0007659376,0.0005383942,0.0007796873,0.0029361967],"category_scores_gemma":[0.0007178245,0.00016313334,0.0004818033,0.0010596486,0.00035840334,0.00096267654,0.00036324104,0.0014161748,0.00085929723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017719886,0.00007008816,0.00028544347,0.008373492,0.0001099895,0.00012838122,0.000023969964,0.00012289164,0.0006918486,0.0013403466,0.020311344,0.9683649],"study_design_scores_gemma":[0.00020129446,0.00034622473,0.0027142302,0.00799736,0.00066910486,0.0024249612,0.00009404147,0.000204663,0.00053658255,0.0019788994,0.98280185,0.0000307306],"about_ca_topic_score_codex":0.00085830095,"about_ca_topic_score_gemma":0.003053276,"teacher_disagreement_score":0.0029361967,"about_ca_system_score_codex":0.00043330155,"about_ca_system_score_gemma":0.00097495096,"threshold_uncertainty_score":0.009822488},"labels":[],"label_agreement":null},{"id":"W1986529943","doi":"10.1007/s11864-000-0051-8","title":"Anaplastic thyroid carcinoma","year":2000,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Malignancy; Surgery; Thyroidectomy; Chemotherapy; Thyroid; Cause of death; Disease; Thyroid carcinoma; Carcinoma; Anaplastic carcinoma; Internal medicine","score_opus":0.1219183256818262,"score_gpt":0.43924084772073996,"score_spread":0.31732252203891376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986529943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027163624,0.9952786,0.00018761687,0.00023572048,0.00039954335,0.000010722836,0.00003841226,0.000018702938,0.003559173],"genre_scores_gemma":[0.002667007,0.9925085,0.0003006852,0.00053985516,0.00044957592,0.000012136084,0.00010450246,0.0000030679323,0.0034146593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986005,0.0000154827,0.000021756365,0.000028861725,0.000056356104,0.000017348102],"domain_scores_gemma":[0.9998317,0.00006774715,0.000033118235,0.000008243058,0.000041832052,0.000017343209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021023901,0.00078022847,0.0012668481,0.0026448988,0.00030706695,0.00068797806,0.0006044253,0.00053672126,0.0059914687],"category_scores_gemma":[0.00054524053,0.00024462224,0.00038230792,0.0023317623,0.00036188852,0.0009409582,0.000542,0.0008859458,0.0035002604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043093634,0.000031944735,0.00030471984,0.007051787,0.000045496898,0.00083561824,0.000031493117,0.00016875671,0.001671808,0.00045750584,0.03861447,0.95074344],"study_design_scores_gemma":[0.000035325484,0.00007741312,0.00217838,0.0027429243,0.00027389667,0.010784844,0.00006659162,0.00009083359,0.0008251235,0.0006367201,0.9822702,0.00001785889],"about_ca_topic_score_codex":0.0022356107,"about_ca_topic_score_gemma":0.005500273,"teacher_disagreement_score":0.0059914687,"about_ca_system_score_codex":0.0005418598,"about_ca_system_score_gemma":0.0010120893,"threshold_uncertainty_score":0.020043433},"labels":[],"label_agreement":null},{"id":"W1989321952","doi":"10.1007/s11864-001-0035-3","title":"Hairy cell leukemia","year":2001,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Deoxycoformycin; Neutropenia; Regimen; Hairy cell leukemia; Hairy Cell; Pentostatin; Febrile neutropenia; Internal medicine; Leukopenia; Gastroenterology; Cladribine; Leukemia; Surgery; Chemotherapy; Rituximab; Lymphoma","score_opus":0.1982134664980968,"score_gpt":0.49475473741481496,"score_spread":0.29654127091671817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989321952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001826635,0.9962435,0.00016874386,0.00030809906,0.0003457918,0.000010415712,0.000023987675,0.000013977029,0.002702835],"genre_scores_gemma":[0.001077503,0.9956583,0.00025541283,0.00047234664,0.00029336615,0.000010721128,0.00005756105,0.0000017951335,0.002173099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998622,0.000022842834,0.000021062235,0.000026892141,0.0000501095,0.000016938919],"domain_scores_gemma":[0.9998185,0.00006949966,0.00003596961,0.000010717553,0.000042175314,0.000023100822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038684774,0.0007492518,0.0014419677,0.0022331688,0.00033608722,0.0008233391,0.0006913824,0.00065071636,0.0066120033],"category_scores_gemma":[0.0005716782,0.0001828069,0.00035232975,0.0022632033,0.00037387633,0.0011479871,0.00070106616,0.001056788,0.0028695713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004708127,0.000044900207,0.00014893479,0.004424102,0.000032650896,0.00023818354,0.0000210484,0.00010789063,0.0009421326,0.0008347831,0.031875372,0.96128285],"study_design_scores_gemma":[0.000035941484,0.000078603654,0.00087363267,0.0021108359,0.0001413125,0.0026481722,0.00004443183,0.000041622454,0.0004903031,0.0007056248,0.99282044,0.000009060716],"about_ca_topic_score_codex":0.0012394723,"about_ca_topic_score_gemma":0.0038705694,"teacher_disagreement_score":0.0066120033,"about_ca_system_score_codex":0.0005468662,"about_ca_system_score_gemma":0.0010673836,"threshold_uncertainty_score":0.022119343},"labels":[],"label_agreement":null},{"id":"W1992830240","doi":"10.1007/s11864-000-0044-7","title":"Fibrous tumors of the pleura","year":2000,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Parietal Pleura; Solitary fibrous tumor; Resection; Radiation therapy; Atypia; Mesenchymal Tumor; Chemotherapy; Pathology; Surgical resection; Radiology; Surgery; Lung; Immunohistochemistry; Internal medicine","score_opus":0.16379476148943808,"score_gpt":0.4657108679892071,"score_spread":0.30191610649976897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992830240","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045037546,0.9968771,0.00021292073,0.00015898161,0.00018062023,0.0000048235956,0.000014561261,0.0000112889165,0.0020893281],"genre_scores_gemma":[0.002741514,0.9954266,0.00033178632,0.00021818258,0.00034445745,0.000004412889,0.000031283733,0.0000019525908,0.0008998659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997936,0.000030779524,0.000045717512,0.000042689713,0.000069670736,0.000017431561],"domain_scores_gemma":[0.99962425,0.00018924773,0.00009701771,0.000015533333,0.000043011336,0.000030955216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038395522,0.00092451595,0.0014031356,0.0049851355,0.00030090052,0.0009271168,0.0008738264,0.000833245,0.0032593452],"category_scores_gemma":[0.0006894151,0.00028143937,0.00036156128,0.0043318453,0.00069477444,0.0017866114,0.0005605243,0.000844366,0.0016779589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000419404,0.00004203887,0.0006124631,0.0081894705,0.00006347293,0.0043480494,0.00009686545,0.00022171729,0.0014912896,0.00068589667,0.014153416,0.97005343],"study_design_scores_gemma":[0.000029148154,0.000118746706,0.0047913697,0.008012777,0.00034467556,0.059373077,0.00035709012,0.00016093034,0.0011026416,0.0015064734,0.92416126,0.000041908665],"about_ca_topic_score_codex":0.00096874725,"about_ca_topic_score_gemma":0.002362827,"teacher_disagreement_score":0.0049851355,"about_ca_system_score_codex":0.0004206215,"about_ca_system_score_gemma":0.0007217815,"threshold_uncertainty_score":0.010903537},"labels":[],"label_agreement":null},{"id":"W1993779176","doi":"10.1007/s11864-010-0131-3","title":"Acupuncture in the Oncology Setting: Clinical Trial Update","year":2010,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Acupuncture Treatment Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Acupuncture; Medicine; Alternative medicine; Clinical trial; Nausea; Clinical Oncology; Intensive care medicine; Vomiting; Oncology; Health care; Cancer; Integrative medicine; Internal medicine; Physical therapy; Pathology","score_opus":0.36484198333567686,"score_gpt":0.6154089993036927,"score_spread":0.2505670159680159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993779176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065344106,0.99748933,0.000103758175,0.0005783221,0.00027751905,0.00016161859,0.00020622127,0.000008344374,0.0005213822],"genre_scores_gemma":[0.0043741935,0.9926779,0.0005926422,0.0014640272,0.00023756211,0.00018694825,0.0001887393,0.0000052717223,0.00027271957],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985891,0.00053836725,0.00045150597,0.00012790089,0.00022945704,0.00006351844],"domain_scores_gemma":[0.98999155,0.006990041,0.0016694319,0.00019344677,0.0009485395,0.00020702413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006083992,0.0011023318,0.006361542,0.0021630905,0.0003269668,0.0023363126,0.0017165673,0.002137533,0.008246391],"category_scores_gemma":[0.014986805,0.0005246149,0.0036429013,0.0031315412,0.00055728137,0.0015820188,0.0007847774,0.0017837851,0.000860849],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006470786,0.00042448714,0.0008595332,0.49452397,0.010811059,0.00018991002,0.00013560808,0.0002507448,0.0011713548,0.0008155895,0.024171451,0.4601755],"study_design_scores_gemma":[0.025258044,0.0052939593,0.011557224,0.45229375,0.14666738,0.0013007765,0.00044859352,0.00041841797,0.0012266643,0.0026034666,0.3527714,0.00016038453],"about_ca_topic_score_codex":0.0023162917,"about_ca_topic_score_gemma":0.010355658,"teacher_disagreement_score":0.008246391,"about_ca_system_score_codex":0.00139429,"about_ca_system_score_gemma":0.005035901,"threshold_uncertainty_score":0.0321756},"labels":[],"label_agreement":null},{"id":"W1995399432","doi":"10.1007/s11864-006-0003-z","title":"Active surveillance versus radical treatment for favorable-risk localized prostate cancer","year":2006,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Watchful waiting; Prostate cancer; Prostatectomy; Prostate-specific antigen; Cancer; Incidence (geometry); Prostate; Internal medicine; Oncology; Gynecology; Surgery","score_opus":0.13702066434122007,"score_gpt":0.46769272392195926,"score_spread":0.3306720595807392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995399432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016839906,0.99928194,0.00003589977,0.00009822865,0.00005848091,0.0000028135344,0.0000092043965,0.0000019091779,0.00034309455],"genre_scores_gemma":[0.0022346415,0.9969772,0.00012652297,0.0002338676,0.00015308069,0.000006165764,0.00002348175,0.0000010555583,0.00024392614],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99985003,0.000036409234,0.00003187232,0.000029828017,0.00004224741,0.000009667905],"domain_scores_gemma":[0.9996131,0.00025463596,0.000084539155,0.000005965248,0.000028284574,0.000013572045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045850954,0.00042358,0.0019038463,0.0010251981,0.00013747519,0.0004849057,0.0006394361,0.0004728229,0.0032392116],"category_scores_gemma":[0.00094975624,0.00018160882,0.0005184127,0.0010864458,0.00028203998,0.0006539966,0.00025112095,0.00096943235,0.0005223391],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000238165,0.000047981597,0.0003028646,0.023452928,0.0001772238,0.000120533725,0.00003072222,0.00015223557,0.00039592563,0.0005504568,0.010735297,0.9637956],"study_design_scores_gemma":[0.0006043356,0.0011518258,0.011065745,0.03739023,0.0035655485,0.006497097,0.00024089072,0.00037402456,0.0010770039,0.0024229316,0.93555623,0.00005417496],"about_ca_topic_score_codex":0.0009066664,"about_ca_topic_score_gemma":0.0032817335,"teacher_disagreement_score":0.0032392116,"about_ca_system_score_codex":0.0003761985,"about_ca_system_score_gemma":0.0005771789,"threshold_uncertainty_score":0.010836244},"labels":[],"label_agreement":null},{"id":"W2005915945","doi":"10.1007/s11864-003-0046-3","title":"Techniques to modulate radiotherapy toxicity and outcome in soft tissue sarcoma","year":2003,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Radiation therapy; Medicine; Soft tissue sarcoma; Radiation treatment planning; Soft tissue; Sarcoma; Outcome (game theory); Medical physics; Radiology; Pathology","score_opus":0.1376600363875104,"score_gpt":0.47756572821689297,"score_spread":0.3399056918293826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005915945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005119326,0.99815,0.00019082488,0.000078743265,0.00007850274,0.000010477377,0.000013665403,0.000008351995,0.0009575254],"genre_scores_gemma":[0.0016587395,0.99723995,0.0003464524,0.00011798663,0.00007619163,0.000013135293,0.000033247266,0.0000021514427,0.0005121307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998535,0.000027013692,0.000025131645,0.000027799579,0.000052778538,0.000013675155],"domain_scores_gemma":[0.99979156,0.00012715971,0.000038371545,0.000008805,0.000025452615,0.000008663822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005347196,0.0007390312,0.0018786713,0.0014989582,0.000248633,0.0007566524,0.0009254364,0.0006977979,0.0028163304],"category_scores_gemma":[0.0005011633,0.0002613607,0.00060208864,0.0015263661,0.00040397188,0.0008574393,0.00039363882,0.0011574654,0.0012632272],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016519266,0.00019792309,0.00021846185,0.014822475,0.00013753535,0.0002589503,0.00005100182,0.0003600208,0.005627039,0.0010852227,0.0062946333,0.97078156],"study_design_scores_gemma":[0.00022662252,0.00082172477,0.0041240575,0.006047796,0.00076298084,0.004757495,0.00013933663,0.00023881979,0.00538499,0.0023415044,0.9751006,0.000054129534],"about_ca_topic_score_codex":0.00079598284,"about_ca_topic_score_gemma":0.0017202359,"teacher_disagreement_score":0.0028163304,"about_ca_system_score_codex":0.00034476953,"about_ca_system_score_gemma":0.000530836,"threshold_uncertainty_score":0.009421527},"labels":[],"label_agreement":null},{"id":"W2006223990","doi":"10.1007/s11864-001-0029-1","title":"Adrenal cortical carcinoma","year":2001,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mitotane; Adrenocortical carcinoma; Chemotherapy; Surgical resection; Endocrine system; Carcinoma; Primary tumor; Disease; Pathogenesis; Oncology; Surgery; Internal medicine; Pathology; Cancer; Hormone; Metastasis","score_opus":0.19454005017584966,"score_gpt":0.4721638713513562,"score_spread":0.27762382117550655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006223990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049672154,0.99257433,0.00040101958,0.00040623994,0.0005348736,0.000008869635,0.00003681533,0.000025593037,0.005515532],"genre_scores_gemma":[0.0056183054,0.98825294,0.0004051569,0.0006591824,0.00078606314,0.000008214891,0.00010210186,0.0000040018085,0.004164046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989355,0.000014251598,0.000014551963,0.000024918385,0.000038504168,0.000014210136],"domain_scores_gemma":[0.9998338,0.00006795397,0.000028642598,0.000013299838,0.00003762206,0.00001865737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018208896,0.0007105471,0.0010034078,0.0021505286,0.00026850333,0.00081640464,0.0005922559,0.0005730505,0.0051980703],"category_scores_gemma":[0.0006282248,0.00020729683,0.00033423046,0.0022883203,0.00034437652,0.0010406218,0.00052100176,0.00089145626,0.0025026463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050149567,0.000028712693,0.00052127783,0.0047819223,0.000052697324,0.0034331349,0.00003149409,0.00023119368,0.0015262217,0.00066965225,0.034639157,0.9540344],"study_design_scores_gemma":[0.00003550153,0.000056707053,0.0028804068,0.0022595122,0.00026532338,0.049619723,0.000101470076,0.00013389272,0.0012878574,0.0010108262,0.9423264,0.00002249434],"about_ca_topic_score_codex":0.0019189032,"about_ca_topic_score_gemma":0.0040122573,"teacher_disagreement_score":0.0051980703,"about_ca_system_score_codex":0.00052136165,"about_ca_system_score_gemma":0.0008519629,"threshold_uncertainty_score":0.017389238},"labels":[],"label_agreement":null},{"id":"W2013328103","doi":"10.1007/s11864-008-0064-2","title":"Mind–Body Interventions in Oncology","year":2008,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Medicine; Psychological intervention; Clinical Oncology; Oncology; Internal medicine; Medical physics; Cancer; Nursing","score_opus":0.4492024423256736,"score_gpt":0.5819832848128068,"score_spread":0.13278084248713323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013328103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080257145,0.9995235,0.000018744913,0.00007302675,0.000044085456,0.0000048955303,0.000006063048,0.0000013552715,0.00024814688],"genre_scores_gemma":[0.000947029,0.9986351,0.0001135985,0.00014534724,0.000047388243,0.000007792942,0.0000073567226,4.5483077e-7,0.00009593498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967647,0.00010855316,0.000069040085,0.000055108474,0.00007196073,0.000018884159],"domain_scores_gemma":[0.998912,0.000878238,0.000116135,0.000014840533,0.000053412034,0.000025374624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010127159,0.000761693,0.0025167156,0.0021976305,0.00031402186,0.000984724,0.00073363056,0.001245956,0.0059550763],"category_scores_gemma":[0.002083155,0.00038200463,0.0010141148,0.0024556315,0.0005494124,0.0010791648,0.00062146387,0.0015026653,0.00062385935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002509126,0.00013895417,0.00018815833,0.106746055,0.00057504454,0.000093979135,0.00007973099,0.0001647073,0.00042464008,0.00092924247,0.005829282,0.8845793],"study_design_scores_gemma":[0.0009111544,0.0009821721,0.008748129,0.22289641,0.0075522736,0.002386355,0.00057861756,0.0003242463,0.0010287868,0.0038608217,0.75064516,0.00008601577],"about_ca_topic_score_codex":0.0021461432,"about_ca_topic_score_gemma":0.006125329,"teacher_disagreement_score":0.0059550763,"about_ca_system_score_codex":0.00060280005,"about_ca_system_score_gemma":0.0013710564,"threshold_uncertainty_score":0.01992172},"labels":[],"label_agreement":null},{"id":"W2021641747","doi":"10.1007/s11864-004-0034-2","title":"Primary multidisciplinary management of extremity soft tissue sarcomas","year":2004,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Neurovascular bundle; Soft tissue; Sarcoma; Synovial sarcoma; Radiology; Magnetic resonance imaging; Soft tissue sarcoma; Radiation therapy; Biopsy; Surgery; Pathology","score_opus":0.1259279128298919,"score_gpt":0.45353530314396673,"score_spread":0.3276073903140748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021641747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003023416,0.9986443,0.00015408,0.000119583274,0.00010126847,0.0000033243023,0.000006620313,0.0000056411636,0.0006628377],"genre_scores_gemma":[0.0019780067,0.9969049,0.00028400635,0.00018443742,0.00020665192,0.0000046828836,0.000028684088,0.0000012282605,0.00040750933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997811,0.00003961002,0.00003900254,0.000043994827,0.00007575729,0.000020557953],"domain_scores_gemma":[0.99967396,0.00015895019,0.000076312645,0.0000075404478,0.00005582535,0.000027472577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039300512,0.0005903032,0.0015397464,0.0018005781,0.0002404046,0.0007074053,0.0008939046,0.0006746404,0.002822492],"category_scores_gemma":[0.0006807421,0.00023275337,0.000538289,0.00160101,0.00027998825,0.000855431,0.0004964633,0.000868292,0.0009996383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005485825,0.000076074066,0.0003868721,0.010286296,0.00009258288,0.0007573024,0.000035522797,0.00030964054,0.0009801956,0.00031470446,0.011685111,0.9750208],"study_design_scores_gemma":[0.00013554837,0.00049085927,0.010891607,0.018344862,0.0010323031,0.040059034,0.00029350352,0.0005985998,0.0018287937,0.0018986696,0.9243668,0.00005945073],"about_ca_topic_score_codex":0.0007700569,"about_ca_topic_score_gemma":0.0025771374,"teacher_disagreement_score":0.002822492,"about_ca_system_score_codex":0.0004104185,"about_ca_system_score_gemma":0.00060258235,"threshold_uncertainty_score":0.009442151},"labels":[],"label_agreement":null},{"id":"W2037730446","doi":"10.1007/s11864-000-0070-5","title":"Localized bladder cancer","year":2000,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Royal College of Physicians and Surgeons of Canada","keywords":"Medicine; Bladder cancer; Cancer; Urology; Oncology; Internal medicine","score_opus":0.16678015950950023,"score_gpt":0.49227819900583614,"score_spread":0.32549803949633593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037730446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018745805,0.9970085,0.00014200337,0.00016756885,0.00022787994,0.000008727245,0.000027205193,0.00001010316,0.00222065],"genre_scores_gemma":[0.0014470961,0.9957526,0.00018599749,0.0003238948,0.00020656585,0.00000901754,0.00006137403,0.0000016042873,0.0020119308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998969,0.000017614786,0.00001589769,0.00002224589,0.000034743523,0.000012712138],"domain_scores_gemma":[0.99989283,0.00003978808,0.000025719022,0.00000535532,0.000025315214,0.000011018026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002325868,0.0006281261,0.001290045,0.0016475564,0.00024294222,0.0006290648,0.0005232687,0.00045353296,0.0060098423],"category_scores_gemma":[0.0004003406,0.00018460686,0.0003905551,0.0017444944,0.0003110322,0.000826014,0.0005363996,0.0008054399,0.002487404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043224627,0.00003704006,0.00019320403,0.010825507,0.000042161202,0.00020960602,0.000028469534,0.00012313666,0.00075357885,0.00059781084,0.03002243,0.9571239],"study_design_scores_gemma":[0.00003562456,0.00012415518,0.0019265726,0.006291035,0.00026015393,0.003954971,0.000069647795,0.000076238386,0.0005068217,0.0006678764,0.9860734,0.000013555074],"about_ca_topic_score_codex":0.0014835409,"about_ca_topic_score_gemma":0.0044185985,"teacher_disagreement_score":0.0060098423,"about_ca_system_score_codex":0.0004097967,"about_ca_system_score_gemma":0.0009207916,"threshold_uncertainty_score":0.020104945},"labels":[],"label_agreement":null},{"id":"W2047220014","doi":"10.1007/s11864-010-0137-x","title":"How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer?","year":2011,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pemetrexed; Lung cancer; Oncology; Epidermal growth factor receptor; Chemotherapy; Vascular endothelial growth factor; Targeted therapy; Internal medicine; Quality of life (healthcare); Cancer; VEGF receptors; Cisplatin","score_opus":0.08467429622991147,"score_gpt":0.42896544193682934,"score_spread":0.3442911457069179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047220014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019054547,0.99522287,0.00018996776,0.002838717,0.0002481406,0.0000033190574,0.000025421063,0.0000033899112,0.0012776408],"genre_scores_gemma":[0.0016229129,0.9963754,0.00023520285,0.00079940906,0.0004138838,0.0000069744683,0.00002243693,0.0000016766522,0.00052217627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996401,0.00008589899,0.000046661327,0.00005191873,0.00014414871,0.000031101976],"domain_scores_gemma":[0.9988998,0.0007325428,0.00017079177,0.000013290569,0.00014546451,0.00003801279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012109425,0.00044051744,0.0017342947,0.0012115608,0.00021265668,0.0012412387,0.00056389376,0.0014009252,0.005759979],"category_scores_gemma":[0.0024378956,0.00022005805,0.00066992996,0.0013432296,0.000615637,0.002624767,0.0004229941,0.0021029145,0.0012639294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011473679,0.000043896136,0.00019667666,0.0069198767,0.00008902562,0.00013244881,0.000021879967,0.00048698537,0.00080095296,0.006160923,0.023716532,0.96131605],"study_design_scores_gemma":[0.00010651606,0.00026890356,0.0023770903,0.009380175,0.00044167665,0.0017813375,0.00016872499,0.00050282176,0.0007078981,0.010941975,0.9732905,0.000032384476],"about_ca_topic_score_codex":0.0016037592,"about_ca_topic_score_gemma":0.003533095,"teacher_disagreement_score":0.005759979,"about_ca_system_score_codex":0.0012295663,"about_ca_system_score_gemma":0.0015051257,"threshold_uncertainty_score":0.01926905},"labels":[],"label_agreement":null},{"id":"W2051653983","doi":"10.1007/s11864-002-0045-9","title":"Elderly patients with lung cancer: Biases and evidence","year":2002,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Lung cancer; Internal medicine; Radiation therapy; Neutropenia; Chemotherapy; Clinical trial; Performance status; Oncology; Cancer; Surgery","score_opus":0.26352508198025576,"score_gpt":0.5318729844685911,"score_spread":0.26834790248833534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051653983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079787377,0.9973424,0.0001236239,0.0009971958,0.00024082467,0.0000637491,0.00015298204,0.000002000822,0.00027940734],"genre_scores_gemma":[0.026569985,0.9677948,0.0010386878,0.003382877,0.00055977685,0.00020786971,0.00022019877,0.000007566694,0.0002181433],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9349551,0.031650316,0.021695333,0.0029808753,0.008173805,0.0005445959],"domain_scores_gemma":[0.65697247,0.29271474,0.03748345,0.004174744,0.008056405,0.0005981878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0754874,0.0014472323,0.0073654973,0.0070013385,0.00070352777,0.004017959,0.002193358,0.0025867647,0.0042162086],"category_scores_gemma":[0.23937261,0.0013355719,0.005115957,0.008976822,0.002196352,0.0034299267,0.0025134173,0.0012702692,0.00034171878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013635207,0.000045342174,0.020600822,0.6481083,0.050597496,0.00034161776,0.0009694713,0.0003253801,0.00018912095,0.0022932312,0.0072365846,0.26792917],"study_design_scores_gemma":[0.001240916,0.00030706287,0.028782098,0.6782164,0.17836192,0.0016198059,0.0014992462,0.0003034312,0.00070690695,0.0064369556,0.10241113,0.00011417236],"about_ca_topic_score_codex":0.0056024017,"about_ca_topic_score_gemma":0.018844927,"teacher_disagreement_score":0.0754874,"about_ca_system_score_codex":0.004315167,"about_ca_system_score_gemma":0.0075181597,"threshold_uncertainty_score":0.3992203},"labels":[],"label_agreement":null},{"id":"W2051710823","doi":"10.1007/s11864-012-0221-5","title":"Active Surveillance for Prostate Cancer: Overview and Update","year":2013,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Overdiagnosis; Medicine; Prostate cancer; Disease; Watchful waiting; Intensive care medicine; Cancer; Adverse effect; Quality of life (healthcare); Gynecology; Internal medicine; Oncology","score_opus":0.1570997929151768,"score_gpt":0.4764837217120425,"score_spread":0.3193839287968657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051710823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051172923,0.9994247,0.000053786003,0.00016482266,0.00008981915,0.000003697964,0.000021473803,0.0000030639633,0.0001874913],"genre_scores_gemma":[0.0004178943,0.9988568,0.00017562776,0.00023398003,0.00016750638,0.0000046375476,0.000035983638,0.0000010167007,0.00010649619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999567,0.00008726054,0.00011158749,0.00007002654,0.00013242765,0.000031823394],"domain_scores_gemma":[0.9983529,0.0008730292,0.00037417506,0.000021506141,0.00029155266,0.000086839194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001312014,0.0009091898,0.001994931,0.0034178866,0.0002220028,0.0012753936,0.0012324472,0.0011397488,0.003481523],"category_scores_gemma":[0.0024931356,0.00043178129,0.0011197696,0.0027546657,0.0004022286,0.0017306966,0.00089972327,0.0017266119,0.0008247049],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012813784,0.00006843664,0.0005943185,0.043110296,0.00028922886,0.00014958375,0.000057006822,0.0003119321,0.00047808682,0.0007992299,0.028313065,0.92570066],"study_design_scores_gemma":[0.0001240896,0.00030284224,0.004027534,0.03776283,0.0018410577,0.0026055868,0.00018644673,0.00036862135,0.0003808791,0.00145675,0.95087665,0.00006658597],"about_ca_topic_score_codex":0.0019363419,"about_ca_topic_score_gemma":0.0055200746,"teacher_disagreement_score":0.003481523,"about_ca_system_score_codex":0.00073438673,"about_ca_system_score_gemma":0.0018640688,"threshold_uncertainty_score":0.011646926},"labels":[],"label_agreement":null},{"id":"W2055188674","doi":"10.1007/s11864-002-0034-z","title":"Follicular thyroid carcinoma","year":2002,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Thyroidectomy; Thyroid carcinoma; Thyroid; Surgery; Follicular carcinoma; Total thyroidectomy; Carcinoma; Follicular phase; Nodule (geology); Internal medicine; Papillary carcinoma","score_opus":0.15706304479701474,"score_gpt":0.43728520014422634,"score_spread":0.2802221553472116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055188674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046209944,0.994402,0.00025484498,0.00029179134,0.00033396218,0.000013271809,0.000039954317,0.000019379475,0.004182685],"genre_scores_gemma":[0.0047592646,0.9891629,0.0004205816,0.000591582,0.00037277033,0.000015853402,0.00013639683,0.0000037284212,0.00453695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998814,0.000017075992,0.000019093333,0.000023523262,0.000044218108,0.000014766684],"domain_scores_gemma":[0.9998616,0.00005483315,0.000026053507,0.000008338724,0.000036263275,0.000012911156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025828846,0.00057298195,0.0011801043,0.0019016151,0.00030766416,0.00066130277,0.000594578,0.00049915427,0.005965388],"category_scores_gemma":[0.0005406984,0.0001821598,0.00034836488,0.0017212795,0.0003143936,0.0008216622,0.0005261851,0.00062637596,0.0025784723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049351005,0.000028092954,0.00033860133,0.005658191,0.00004022004,0.00062906934,0.000033668683,0.00012066985,0.001440842,0.0004893925,0.02597117,0.96520066],"study_design_scores_gemma":[0.00003539748,0.000086670036,0.0019034216,0.0021270472,0.00027136368,0.01011954,0.000077106364,0.00008032411,0.0009778112,0.00049598207,0.98381215,0.0000132481155],"about_ca_topic_score_codex":0.0026456108,"about_ca_topic_score_gemma":0.005846113,"teacher_disagreement_score":0.005965388,"about_ca_system_score_codex":0.00059692643,"about_ca_system_score_gemma":0.0009612215,"threshold_uncertainty_score":0.019956172},"labels":[],"label_agreement":null},{"id":"W2058686345","doi":"10.1007/s11864-004-0044-0","title":"Adenocarcinoma of the cervix","year":2004,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Adenocarcinoma; Stage (stratigraphy); Cervix; Radiation therapy; Hysterectomy; Radical Hysterectomy; Cervical cancer; Incidence (geometry); Disease; Surgery; Radical surgery; Oncology; Internal medicine; Cancer","score_opus":0.18088694354339682,"score_gpt":0.46256375068650873,"score_spread":0.28167680714311194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058686345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019786444,0.9976178,0.00008814143,0.00013057193,0.00017011982,0.000008822397,0.000029265331,0.0000053874815,0.0017520185],"genre_scores_gemma":[0.0014182284,0.996808,0.00013568485,0.00023259442,0.00013596074,0.00000705391,0.00006203769,9.72016e-7,0.0011994456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998024,0.000036654117,0.000028836457,0.000038300444,0.00006912982,0.000024653182],"domain_scores_gemma":[0.99979895,0.000091654605,0.00004506889,0.000008997811,0.000037363316,0.000018027906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033189726,0.0007589626,0.0016831069,0.0028251105,0.00037204064,0.0009911942,0.0006927123,0.0008165844,0.006032255],"category_scores_gemma":[0.0006674983,0.00030324908,0.0005482281,0.0024424444,0.00045557204,0.0009043295,0.0006905549,0.0009888192,0.0024651964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000678757,0.00004214808,0.0004367451,0.016396172,0.000074268435,0.0006947752,0.000045606248,0.00018475692,0.001465972,0.00079281867,0.021597678,0.9582012],"study_design_scores_gemma":[0.00005206798,0.00015925404,0.0028862038,0.00941857,0.00038517063,0.010181397,0.00013693617,0.000078141835,0.0011127987,0.0007077056,0.9748589,0.000022882803],"about_ca_topic_score_codex":0.0027064802,"about_ca_topic_score_gemma":0.007228653,"teacher_disagreement_score":0.006032255,"about_ca_system_score_codex":0.0004786749,"about_ca_system_score_gemma":0.001273252,"threshold_uncertainty_score":0.020179927},"labels":[],"label_agreement":null},{"id":"W2066277295","doi":"10.1007/s11864-004-0036-0","title":"Rehabilitation and quality-of-life issues in patients with extremity soft tissue sarcoma","year":2004,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Rehabilitation; Psychosocial; Quality of life (healthcare); Lymphedema; Psychological intervention; Physical therapy; International Classification of Functioning, Disability and Health; Activities of daily living; Physical medicine and rehabilitation; Nursing; Cancer; Psychiatry; Breast cancer","score_opus":0.10833315536884193,"score_gpt":0.4519321452570108,"score_spread":0.3435989898881689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066277295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044064055,0.99887484,0.00004136059,0.0001281771,0.000043760872,0.0000022985125,0.000009293737,0.0000017317585,0.00045793195],"genre_scores_gemma":[0.0032773458,0.9960771,0.00013085532,0.00016100453,0.00006998225,0.0000057646225,0.000025560374,4.279957e-7,0.00025175847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998228,0.00003907107,0.00003684788,0.000025212878,0.00006167181,0.000014558553],"domain_scores_gemma":[0.9997471,0.0001337651,0.00006436336,0.0000033304116,0.000039278624,0.0000121608045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037757834,0.00045389085,0.0016039662,0.0013628218,0.00020088576,0.00066160096,0.0004593639,0.0006250589,0.0016876479],"category_scores_gemma":[0.000749634,0.0001521183,0.00054100255,0.0020372197,0.00024692828,0.00062387064,0.000346568,0.000639023,0.00039094882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009210331,0.000114690585,0.0015534464,0.017084189,0.00020866212,0.00030402344,0.0000672428,0.00019314735,0.0005327043,0.00041791366,0.0070579723,0.97237384],"study_design_scores_gemma":[0.00022862294,0.00092725817,0.06738439,0.0483527,0.0029559499,0.01882928,0.0011053465,0.0006235864,0.0012874184,0.0029596633,0.85523915,0.0001066567],"about_ca_topic_score_codex":0.0015669835,"about_ca_topic_score_gemma":0.0043063685,"teacher_disagreement_score":0.0016876479,"about_ca_system_score_codex":0.0003745549,"about_ca_system_score_gemma":0.00083956274,"threshold_uncertainty_score":0.005645752},"labels":[],"label_agreement":null},{"id":"W2084667136","doi":"10.1007/s11864-006-0002-0","title":"Should finasteride be used to prevent prostate cancer?","year":2006,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Finasteride; Prostate cancer; Dutasteride; Prostate; Internal medicine; Cancer; Regimen; Placebo; Prostate biopsy; Urology; Gynecology; Oncology; Pathology; Alternative medicine","score_opus":0.2566947204762712,"score_gpt":0.4982076700975717,"score_spread":0.24151294962130054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084667136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026784785,0.9944845,0.00009848667,0.0028066826,0.00067363336,0.0000057741854,0.000039314968,0.000010023496,0.0016137918],"genre_scores_gemma":[0.0025101309,0.99195474,0.00020619525,0.0024717005,0.0012005026,0.000010808795,0.000045759443,0.000002281677,0.001597908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999708,0.000057971818,0.0000653972,0.000042680276,0.00010182039,0.000024117877],"domain_scores_gemma":[0.9994282,0.00028445543,0.00015533598,0.000014936969,0.00007809354,0.00003899063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007881428,0.0006123378,0.002488952,0.0012280354,0.0002863079,0.00088243483,0.00073824875,0.0015500836,0.006590952],"category_scores_gemma":[0.0018758043,0.0003085307,0.0008762367,0.0012171732,0.00061927066,0.0014399567,0.0003566463,0.002077135,0.0025252805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003597948,0.00007437003,0.0005631133,0.011523188,0.00026153572,0.00046852394,0.000041999596,0.00014239561,0.0006024412,0.0013373967,0.04375359,0.9408717],"study_design_scores_gemma":[0.00058765244,0.0004984018,0.0053279903,0.011359546,0.0013142177,0.0050092163,0.00020025815,0.0001782402,0.00068120536,0.0036647301,0.97112185,0.000056705776],"about_ca_topic_score_codex":0.0029322682,"about_ca_topic_score_gemma":0.010836532,"teacher_disagreement_score":0.006590952,"about_ca_system_score_codex":0.0007174467,"about_ca_system_score_gemma":0.0017348686,"threshold_uncertainty_score":0.02204895},"labels":[],"label_agreement":null},{"id":"W2087083130","doi":"10.1007/s11864-004-0021-7","title":"Primary thyroid lymphomas","year":2004,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Thyroid lymphoma; Vincristine; Thyroid; Lymphoma; Radiation therapy; Pathology; Prednisone; Cyclophosphamide; Rituximab; MALT lymphoma; Chemotherapy; Oncology; Internal medicine; Thyroiditis","score_opus":0.11380103128319352,"score_gpt":0.4442673289081999,"score_spread":0.3304662976250064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087083130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024622006,0.9974849,0.00013716043,0.00018045137,0.00016859827,0.000007175242,0.000023549048,0.000011878847,0.0017401528],"genre_scores_gemma":[0.0021228504,0.99541,0.00022175007,0.0003850667,0.0002356891,0.000009329199,0.000069407215,0.0000021406042,0.0015437285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983,0.000026422429,0.000032815857,0.000031648186,0.00005528909,0.000023806317],"domain_scores_gemma":[0.9997882,0.000092342525,0.000046920202,0.000008272743,0.000046381792,0.000017904335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000303805,0.0007000276,0.0016401331,0.002110511,0.00022182315,0.000857904,0.0006082495,0.0006153367,0.0060123038],"category_scores_gemma":[0.0006539795,0.00026829194,0.00045657327,0.0018877722,0.00031076837,0.0009508074,0.0005550917,0.0009340161,0.0021588318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076108554,0.000040639294,0.0003381578,0.011043482,0.000065239496,0.0006691089,0.00003750911,0.00018480634,0.0012201624,0.00048182294,0.024355143,0.9614879],"study_design_scores_gemma":[0.00007571107,0.00013758054,0.0025071965,0.0070435465,0.0006243825,0.012019844,0.0001165287,0.00012683704,0.0011131051,0.0007799384,0.9754361,0.00001927373],"about_ca_topic_score_codex":0.0016847831,"about_ca_topic_score_gemma":0.004447326,"teacher_disagreement_score":0.0060123038,"about_ca_system_score_codex":0.0006587276,"about_ca_system_score_gemma":0.0009812649,"threshold_uncertainty_score":0.02011311},"labels":[],"label_agreement":null},{"id":"W2088453201","doi":"10.1007/s11864-008-0063-3","title":"Acupuncture as an Evidence-Based Option for Symptom Control in Cancer Patients","year":2008,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Acupuncture Treatment Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Acupuncture; Nausea; Randomized controlled trial; Clinical trial; Vomiting; Central nervous system; Physical therapy; Physical medicine and rehabilitation; Intensive care medicine; Anesthesia; Alternative medicine; Surgery; Internal medicine; Pathology","score_opus":0.23841671953166124,"score_gpt":0.5383749176735155,"score_spread":0.2999581981418543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088453201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024738218,0.99925536,0.00003749591,0.00009721684,0.000047078785,0.000015951073,0.000014803926,0.0000014360361,0.00028326447],"genre_scores_gemma":[0.0038189576,0.9954465,0.0003387816,0.00020763866,0.00005691074,0.000016738348,0.000024563384,7.067979e-7,0.00008909568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999127,0.0003322159,0.00020934279,0.00007673702,0.00022901886,0.0000256527],"domain_scores_gemma":[0.9971859,0.0023392693,0.00030514377,0.000029339972,0.00010828416,0.00003198905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022702387,0.0006307563,0.003496211,0.0022544134,0.00027858102,0.0011808494,0.0010629598,0.0013486351,0.0056587784],"category_scores_gemma":[0.0043252283,0.000352875,0.0019221663,0.0025892523,0.0004612149,0.000949474,0.00043252285,0.0013377615,0.00031105443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010698343,0.00018142661,0.0004234272,0.3677686,0.004175537,0.00016857346,0.00010801394,0.0002444964,0.0007203151,0.0012197454,0.004717844,0.61920226],"study_design_scores_gemma":[0.0058445833,0.0027143569,0.016264038,0.6188528,0.04846933,0.0029571378,0.00092539977,0.0007605266,0.0018629999,0.00525692,0.29593533,0.00015660908],"about_ca_topic_score_codex":0.0023021586,"about_ca_topic_score_gemma":0.00720888,"teacher_disagreement_score":0.0056587784,"about_ca_system_score_codex":0.0007305315,"about_ca_system_score_gemma":0.0014888671,"threshold_uncertainty_score":0.018930495},"labels":[],"label_agreement":null},{"id":"W2089360403","doi":"10.1007/s11864-015-0335-7","title":"Soft Tissue Sarcoma and Radiation Therapy Advances, Impact on Toxicity","year":2015,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Radiation therapy; Image-guided radiation therapy; Pazopanib; Soft tissue sarcoma; Clinical trial; Soft tissue; Sarcoma; Radiology; Oncology; Cancer; Internal medicine; Pathology","score_opus":0.1342204740566365,"score_gpt":0.4882577170840611,"score_spread":0.3540372430274246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089360403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096326665,0.9988508,0.000036777983,0.00023369385,0.0001020489,0.0000022447343,0.000021308537,0.0000027399649,0.00065398397],"genre_scores_gemma":[0.0005878491,0.9987501,0.00008054585,0.00020343761,0.00012794469,0.0000023340478,0.000021750067,8.592323e-7,0.00022510932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997466,0.00003953461,0.000054124255,0.00004285756,0.00009699896,0.000019883573],"domain_scores_gemma":[0.99934906,0.0003733498,0.000121527235,0.000012413155,0.000117107236,0.00002658385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007598668,0.00051027496,0.001200532,0.0020790237,0.00020970266,0.0010820745,0.00056198554,0.0006964483,0.0046794345],"category_scores_gemma":[0.0015308332,0.0002623696,0.00057426706,0.0026307367,0.0004086825,0.0012985949,0.00063014793,0.0012919294,0.00096121104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075521784,0.000042952666,0.00043933556,0.027515694,0.00014124945,0.00011026608,0.000053034506,0.00033112193,0.0006041487,0.001972052,0.025440749,0.94327384],"study_design_scores_gemma":[0.000033293803,0.00008994344,0.0021685665,0.01244177,0.00044631495,0.0013833274,0.00011075552,0.0001301823,0.00030308153,0.0020674833,0.9808019,0.00002356197],"about_ca_topic_score_codex":0.0014304842,"about_ca_topic_score_gemma":0.003892293,"teacher_disagreement_score":0.0046794345,"about_ca_system_score_codex":0.0006542843,"about_ca_system_score_gemma":0.001522602,"threshold_uncertainty_score":0.015654266},"labels":[],"label_agreement":null},{"id":"W2091163157","doi":"10.1007/s11864-001-0017-5","title":"Limited stage small cell lung cancer","year":2001,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Radiation therapy; Prophylactic cranial irradiation; Chemotherapy; Oncology; Stage (stratigraphy); Cisplatin; Lung cancer; Internal medicine; Surgery; Conventional PCI","score_opus":0.23981062934101902,"score_gpt":0.5337653040662865,"score_spread":0.2939546747252675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091163157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005156361,0.99926656,0.00003154889,0.00012057879,0.00010241258,0.0000051404645,0.000012642064,0.000002353162,0.00040721975],"genre_scores_gemma":[0.00042414907,0.9989454,0.00007981804,0.0001629192,0.00007418237,0.0000065767294,0.000017895041,4.116674e-7,0.00028868468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972624,0.00006911428,0.000064331216,0.000043924414,0.00007734167,0.000019041858],"domain_scores_gemma":[0.9992785,0.00043242885,0.00012780791,0.000018004832,0.000109382796,0.00003395392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097373716,0.00071078417,0.0027016646,0.002844811,0.00029579547,0.00094808725,0.00067575654,0.0007623971,0.004676426],"category_scores_gemma":[0.0015717773,0.00030129464,0.0006328057,0.0040268437,0.000489406,0.001350675,0.00055462687,0.0009063541,0.0012930933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011402854,0.000045762845,0.0002674168,0.043135956,0.00015918179,0.00016790595,0.00003813683,0.00015681557,0.00053664995,0.0007437006,0.025631957,0.92900246],"study_design_scores_gemma":[0.00010394496,0.00022317278,0.0025956505,0.021390356,0.0010686856,0.0017610331,0.000147075,0.00007398732,0.00038225795,0.00088767643,0.9713458,0.0000204213],"about_ca_topic_score_codex":0.0022267702,"about_ca_topic_score_gemma":0.007865011,"teacher_disagreement_score":0.004676426,"about_ca_system_score_codex":0.00097261113,"about_ca_system_score_gemma":0.001798715,"threshold_uncertainty_score":0.015644193},"labels":[],"label_agreement":null},{"id":"W2121455177","doi":"10.1007/s11864-010-0136-y","title":"Gastric Cancer Surgery: An American Perspective on the Current Options and Standards","year":2011,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Medicine; Cancer; Lymphadenectomy; Population; Gastrectomy; General surgery; Surgery; Disease; Natural history; Stage (stratigraphy); Internal medicine","score_opus":0.18272436065326786,"score_gpt":0.48515096498500315,"score_spread":0.3024266043317353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121455177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049634735,0.99592316,0.00005067087,0.0029669518,0.00042622077,0.0000015500199,0.000010643458,0.0000033245014,0.00056785176],"genre_scores_gemma":[0.000404405,0.9977048,0.0001438544,0.00095929793,0.00058899977,0.000002499575,0.00001326137,7.28373e-7,0.00018216735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994511,0.00011036715,0.00010976004,0.000060587514,0.00023081093,0.000037474798],"domain_scores_gemma":[0.99765307,0.0010186473,0.000421803,0.00004180763,0.00067566626,0.00018903222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022443421,0.0007238766,0.0014701448,0.0030529073,0.00046828185,0.0019198046,0.0010166735,0.0017703116,0.003315918],"category_scores_gemma":[0.002924633,0.0003166856,0.00070726004,0.0043565542,0.0009735294,0.0036048393,0.0010627082,0.0035538292,0.0010098562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100675665,0.000073096984,0.00055608747,0.0142178135,0.000096047064,0.00017065917,0.0000836563,0.00030920305,0.000488911,0.006862653,0.097359024,0.8796822],"study_design_scores_gemma":[0.00003154394,0.000092892085,0.00187603,0.014713926,0.00021569406,0.0009483391,0.0002568245,0.00015665387,0.00014235638,0.00431281,0.97721237,0.000040623836],"about_ca_topic_score_codex":0.0028308034,"about_ca_topic_score_gemma":0.007779609,"teacher_disagreement_score":0.003315918,"about_ca_system_score_codex":0.0015468701,"about_ca_system_score_gemma":0.003573549,"threshold_uncertainty_score":0.011869311},"labels":[],"label_agreement":null},{"id":"W2266388176","doi":"10.1007/s11864-015-0383-z","title":"Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour","year":2016,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Centre Hospitalier Universitaire de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Sacrum; Surgery; Adverse effect; Quality of life (healthcare); Chordoma; Referral; General surgery; Internal medicine","score_opus":0.1828155753395027,"score_gpt":0.4626293385484711,"score_spread":0.2798137632089684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266388176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039682456,0.9988494,0.00003291917,0.00012956082,0.00006320557,0.0000036392587,0.00004215698,0.0000016328803,0.00048053934],"genre_scores_gemma":[0.00414375,0.9951514,0.00011228422,0.00021831809,0.00010273715,0.00000800873,0.000068128895,7.525376e-7,0.00019453367],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99977,0.000043835946,0.000056256413,0.000033414908,0.00007328339,0.00002321819],"domain_scores_gemma":[0.9995921,0.00022609723,0.00010842916,0.000004649423,0.00005293969,0.000015844435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005270229,0.0004972893,0.0014159065,0.0015360789,0.00016807401,0.0006978728,0.0004681366,0.00048919476,0.0027287623],"category_scores_gemma":[0.0013483583,0.00012923712,0.00091698754,0.0019781336,0.0002853756,0.0005457131,0.00048291322,0.00083350675,0.00031133747],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019953225,0.000090618014,0.0015113709,0.051798113,0.0008114569,0.00013995268,0.00006881204,0.00020321248,0.0004077768,0.0005925676,0.009042891,0.93513376],"study_design_scores_gemma":[0.00034044663,0.0010585123,0.057113674,0.105481446,0.0073908884,0.0041924617,0.00081742136,0.00040730467,0.0010022843,0.003901184,0.8181613,0.00013307323],"about_ca_topic_score_codex":0.0019236213,"about_ca_topic_score_gemma":0.0054847104,"teacher_disagreement_score":0.0027287623,"about_ca_system_score_codex":0.00052589,"about_ca_system_score_gemma":0.0009990942,"threshold_uncertainty_score":0.00912863},"labels":[],"label_agreement":null},{"id":"W2277678255","doi":"10.1007/s11864-015-0381-1","title":"Molecular Predictors of Radiotherapy Response in Sarcoma","year":2015,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Radiation therapy; Medicine; Sarcoma; Soft tissue sarcoma; Pathology; Cancer; Pathological; Soft tissue; Oncology; Internal medicine","score_opus":0.1218713074569151,"score_gpt":0.4591788035450592,"score_spread":0.3373074960881441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277678255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020317074,0.9991393,0.0000730891,0.00019046213,0.000066403074,0.0000028253635,0.000025781728,0.0000038774942,0.00029503374],"genre_scores_gemma":[0.0020046516,0.99709904,0.00021214757,0.00025035502,0.00015279745,0.0000056442805,0.00006484225,0.0000011748616,0.00020946511],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997677,0.000047739628,0.000045866203,0.00005225731,0.00006609559,0.000020272922],"domain_scores_gemma":[0.9992256,0.0004922201,0.00015961548,0.000014322699,0.00008663689,0.000021613845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071647036,0.0006191399,0.0016974532,0.0014464518,0.00014384929,0.00094416516,0.00075074885,0.0006580806,0.0021773726],"category_scores_gemma":[0.0019071827,0.00036275032,0.00075995154,0.001463825,0.00034510132,0.00095083914,0.00053582905,0.0012774458,0.000640988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012928744,0.000048077563,0.0019576221,0.015772283,0.00032842424,0.00012561753,0.000035403376,0.00050549384,0.0006824056,0.0010585409,0.0136279985,0.96572876],"study_design_scores_gemma":[0.00012850287,0.00037682822,0.019008314,0.030268751,0.003590448,0.0034057116,0.00021175553,0.00091570686,0.0017760781,0.0052914866,0.93491685,0.00010958297],"about_ca_topic_score_codex":0.0014863805,"about_ca_topic_score_gemma":0.0029286584,"teacher_disagreement_score":0.0021773726,"about_ca_system_score_codex":0.0005684599,"about_ca_system_score_gemma":0.0010398835,"threshold_uncertainty_score":0.007284105},"labels":[],"label_agreement":null},{"id":"W2342232619","doi":"10.1007/s11864-016-0407-3","title":"SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?","year":2016,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; SABR volatility model; Lung cancer; Resection; Cancer; Oncology; Lung; Internal medicine; Surgery","score_opus":0.12307388796009591,"score_gpt":0.46414019256516215,"score_spread":0.34106630460506626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342232619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075943106,0.99850106,0.000030358835,0.0009055716,0.00021352746,0.0000017640501,0.000017772274,0.000002098811,0.00025184124],"genre_scores_gemma":[0.0008523034,0.9975943,0.000111840585,0.00089982164,0.00032556546,0.0000038897997,0.000030626616,0.0000012659995,0.00018032528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974483,0.00005707172,0.000065637054,0.00004282145,0.00006382009,0.000025836007],"domain_scores_gemma":[0.9992244,0.00047650095,0.00014461133,0.0000118418375,0.00010915295,0.00003347614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010480938,0.0003982218,0.0019435596,0.0008362545,0.00016993267,0.0011781119,0.00081553345,0.0010592362,0.0043002227],"category_scores_gemma":[0.0018771107,0.00021151638,0.0010816951,0.0011972734,0.00045237644,0.0017289525,0.00061011413,0.0023682693,0.0009902074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026022943,0.000046160912,0.00045206843,0.04071691,0.0003811975,0.000116559735,0.00005699406,0.00015460872,0.00052703195,0.0027685869,0.033123203,0.92139643],"study_design_scores_gemma":[0.00026008533,0.0003080588,0.0032306325,0.042390447,0.0015573142,0.001516279,0.00025171772,0.00013734425,0.000223544,0.0032605045,0.94681954,0.0000445204],"about_ca_topic_score_codex":0.0013333153,"about_ca_topic_score_gemma":0.004633266,"teacher_disagreement_score":0.0043002227,"about_ca_system_score_codex":0.00056138885,"about_ca_system_score_gemma":0.0014295643,"threshold_uncertainty_score":0.0143857},"labels":[],"label_agreement":null},{"id":"W2618230854","doi":"10.1007/s11864-017-0484-y","title":"Overview of the 8th Edition TNM Classification for Head and Neck Cancer","year":2017,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":687,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Head and neck cancer; Stage (stratigraphy); Cancer; Oncology; Head and neck; Merkel cell carcinoma; Internal medicine; Sarcoma; Skin cancer; Cancer staging; Carcinoma; Pathology; Surgery","score_opus":0.5632878262471015,"score_gpt":0.5804980947292319,"score_spread":0.017210268482130364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618230854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009491662,0.9974355,0.00014436993,0.00068476866,0.00037591156,0.000022585622,0.00023568473,0.000007976214,0.0009983104],"genre_scores_gemma":[0.00055408635,0.99773717,0.00046250725,0.00040838023,0.00021295065,0.000021020398,0.0002743739,0.0000021648818,0.00032727394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99918884,0.00015953383,0.0002410656,0.00009534188,0.00025784865,0.00005730907],"domain_scores_gemma":[0.998823,0.0005256055,0.00022316707,0.00001923924,0.00035931857,0.00004963041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018112375,0.0011017859,0.0020365578,0.0066251867,0.00044622368,0.0013347911,0.001421457,0.0010132756,0.006124862],"category_scores_gemma":[0.0030542559,0.00035854705,0.001879216,0.006527093,0.0005048032,0.0017064103,0.0009479558,0.0015164245,0.0013968805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014872954,0.000058370053,0.0011216315,0.072449334,0.00035108943,0.0001333704,0.00009938439,0.00036535357,0.0005875794,0.0040058545,0.08518609,0.8354932],"study_design_scores_gemma":[0.000044867767,0.00010068855,0.0037629465,0.045139812,0.00094829156,0.0009919655,0.00015452366,0.0001443322,0.0002538979,0.0023598182,0.9460539,0.000044876586],"about_ca_topic_score_codex":0.0078437785,"about_ca_topic_score_gemma":0.014421118,"teacher_disagreement_score":0.0078437785,"about_ca_system_score_codex":0.0017511752,"about_ca_system_score_gemma":0.005667226,"threshold_uncertainty_score":0.020489693},"labels":[],"label_agreement":null},{"id":"W2618749156","doi":"10.1007/s11864-017-0482-0","title":"The Cisplatin Total Dose and Concomitant Radiation in Locoregionally Advanced Head and Neck Cancer: Any Recent Evidence for Dose Efficacy?","year":2017,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Head and neck cancer; Regimen; Radiation therapy; Clinical trial; Chemoradiotherapy; Oncology; Concomitant; Cisplatin; Cumulative dose; Randomized controlled trial; Intensive care medicine; Internal medicine; Chemotherapy","score_opus":0.3261756068688651,"score_gpt":0.538794438171456,"score_spread":0.2126188313025909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618749156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019799074,0.999328,0.000021691478,0.00013986418,0.00006229193,0.0000065373556,0.000024160176,0.000001169144,0.00021827886],"genre_scores_gemma":[0.0027417524,0.9964407,0.00013650961,0.0004549613,0.00008885561,0.000011094053,0.000033541386,0.0000014439452,0.00009125158],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9992673,0.0002706453,0.0002023872,0.00009978937,0.00013373213,0.000026126274],"domain_scores_gemma":[0.9977049,0.0017070589,0.0003855575,0.00003776214,0.00012802843,0.000036662717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00210349,0.0005336265,0.0035038348,0.0013321635,0.00013532116,0.0011441675,0.0011687625,0.00096431235,0.0054403534],"category_scores_gemma":[0.0052394657,0.00038634226,0.0025336707,0.001954195,0.0005176557,0.0013365657,0.0005815748,0.001627859,0.00044008976],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016054435,0.00010394016,0.0010241712,0.26368326,0.006752424,0.00008811037,0.000085247906,0.00042162844,0.00065073534,0.0014557117,0.009984357,0.71414495],"study_design_scores_gemma":[0.0035584804,0.0028657059,0.015827281,0.26181668,0.072349265,0.0017539199,0.00046196388,0.0004320483,0.0011957266,0.003730582,0.63588023,0.00012825766],"about_ca_topic_score_codex":0.0018183854,"about_ca_topic_score_gemma":0.004836444,"teacher_disagreement_score":0.0054403534,"about_ca_system_score_codex":0.00074478734,"about_ca_system_score_gemma":0.0015512753,"threshold_uncertainty_score":0.018199801},"labels":[],"label_agreement":null},{"id":"W2765940870","doi":"10.1007/s11864-017-0508-7","title":"Optimal Therapies for Newly Diagnosed Elderly Patients with Glioblastoma","year":2017,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Accuray; Elekta; Brain Tumour Research; Varian Medical Systems; Medtronic","keywords":"Medicine; Contraindication; Radiation therapy; Glioblastoma; Temozolomide; Chemotherapy; Oncology; Internal medicine; Adjuvant; Surgery; Pathology; Alternative medicine","score_opus":0.10900599538897555,"score_gpt":0.4289440688693058,"score_spread":0.31993807348033027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765940870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014111742,0.99901724,0.000054545984,0.0002454355,0.000083518134,0.0000033838137,0.000017744042,0.0000030581903,0.000433893],"genre_scores_gemma":[0.0013848584,0.9976999,0.00018883929,0.00036715958,0.00013567161,0.000006745056,0.000036875976,0.0000010712179,0.00017880462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999859,0.00003068066,0.000040440504,0.000023204388,0.00003240937,0.000014289892],"domain_scores_gemma":[0.9997563,0.00012449168,0.000062710926,0.0000050869166,0.00003845371,0.00001300745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035872616,0.0005843201,0.0014123188,0.001143437,0.00018527149,0.00069614575,0.0006339031,0.00065514195,0.0027677275],"category_scores_gemma":[0.0010410934,0.00020867486,0.0006710962,0.00082067976,0.00022608187,0.0009438885,0.0004797461,0.0013048844,0.00058849354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014461967,0.000059117247,0.0003786209,0.025131235,0.0002469527,0.0001525344,0.00005097246,0.0003024594,0.0005391922,0.001232755,0.020362688,0.9513988],"study_design_scores_gemma":[0.00029012284,0.00037755954,0.003887191,0.039462388,0.002283484,0.002610716,0.00021889621,0.0004034731,0.00082250603,0.004661676,0.9449205,0.00006155519],"about_ca_topic_score_codex":0.0010791708,"about_ca_topic_score_gemma":0.0037992513,"teacher_disagreement_score":0.0027677275,"about_ca_system_score_codex":0.00045084322,"about_ca_system_score_gemma":0.0009038743,"threshold_uncertainty_score":0.009259045},"labels":[],"label_agreement":null},{"id":"W2769777633","doi":"10.1007/s11864-017-0516-7","title":"Combined Vertebral Augmentation and Radiofrequency Ablation in the Management of Spinal Metastases: an Update","year":2017,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Radiofrequency ablation; Radiosurgery; Surgery; Percutaneous; Radiation therapy; Metastasis; Quality of life (healthcare); Radiology; Cancer; Ablation; Internal medicine","score_opus":0.2386865697659212,"score_gpt":0.508018577923553,"score_spread":0.2693320081576318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769777633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011266485,0.99907446,0.000089836074,0.00018983704,0.0001238713,0.000002867208,0.000013784943,0.000003995889,0.0003886852],"genre_scores_gemma":[0.000729209,0.9982712,0.00024142118,0.0002717057,0.0002663976,0.0000036363892,0.00002686587,0.0000012722767,0.00018820379],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997868,0.000035311714,0.000047029625,0.000038111295,0.000077358156,0.000015403157],"domain_scores_gemma":[0.9993636,0.0003853091,0.00010069191,0.0000091199445,0.00011062197,0.000030679705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056840194,0.0005988717,0.0013680839,0.002011524,0.00020392238,0.0010362718,0.00091011066,0.0010045264,0.0037609427],"category_scores_gemma":[0.0012966632,0.0002442447,0.000773043,0.0015238458,0.00035994692,0.0013018914,0.00052049494,0.0014176794,0.0009441449],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009187793,0.000078500176,0.00037164957,0.021945463,0.00018003826,0.00031723126,0.00004418091,0.00030350953,0.0009916389,0.000892504,0.022302281,0.95248115],"study_design_scores_gemma":[0.00011900715,0.00027933507,0.0029478706,0.016481148,0.0013108446,0.0074419132,0.00013770003,0.00047346554,0.00065774005,0.0018460572,0.9682442,0.00006072989],"about_ca_topic_score_codex":0.0011211818,"about_ca_topic_score_gemma":0.0033627127,"teacher_disagreement_score":0.0037609427,"about_ca_system_score_codex":0.0003717269,"about_ca_system_score_gemma":0.0010833772,"threshold_uncertainty_score":0.012581587},"labels":[],"label_agreement":null},{"id":"W2791438625","doi":"10.1007/s11864-018-0532-2","title":"When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nilotinib; Chronic myelogenous leukemia; Dasatinib; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Myeloid leukemia; Clinical trial; Clinical endpoint; Intensive care medicine; Imatinib; Leukemia; Cancer","score_opus":0.10711034678265129,"score_gpt":0.4213271519235706,"score_spread":0.3142168051409193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791438625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021384968,0.951517,0.00039898045,0.03748584,0.006034623,0.000030063895,0.00014059087,0.000025976331,0.0041530197],"genre_scores_gemma":[0.0016615237,0.9738947,0.0006870158,0.01717078,0.0038727673,0.000037497808,0.0001987643,0.0000091277625,0.0024677017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928683,0.00016358764,0.00014934523,0.0000751273,0.0002849791,0.000040150015],"domain_scores_gemma":[0.9984034,0.00067566294,0.00027251896,0.000029676325,0.0005411111,0.00007769738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012686665,0.0004215637,0.000933896,0.0010222723,0.0002806401,0.0010328208,0.0014954582,0.0028307335,0.0058935545],"category_scores_gemma":[0.003518346,0.00017947286,0.00068088394,0.0008629054,0.0005685287,0.0025587548,0.0005461117,0.0032942898,0.0039065117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077070225,0.000039828537,0.00017207758,0.015403092,0.0000841241,0.0002752299,0.00007307002,0.00013148815,0.00058986986,0.003874627,0.3685492,0.6107303],"study_design_scores_gemma":[0.000031835734,0.000036838537,0.00038421282,0.0077931723,0.000081245176,0.0009406072,0.00005903434,0.00005407741,0.00015756082,0.0024932525,0.98795414,0.0000141156015],"about_ca_topic_score_codex":0.000807412,"about_ca_topic_score_gemma":0.0017274069,"teacher_disagreement_score":0.0058935545,"about_ca_system_score_codex":0.0005718387,"about_ca_system_score_gemma":0.0014778319,"threshold_uncertainty_score":0.019715905},"labels":[],"label_agreement":null},{"id":"W2851342260","doi":"10.1007/s11864-018-0554-9","title":"Head and Neck Cancer Survivorship Care: A Review of the Current Guidelines and Remaining Unmet Needs","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Cancer Australia","keywords":"Medicine; Survivorship curve; Multidisciplinary approach; Quality of life (healthcare); Family medicine; Head and neck cancer; Cancer survivorship; Disease; Health care; Head and neck; Cancer; MEDLINE; Gerontology; Nursing; Surgery; Internal medicine","score_opus":0.2986488952729773,"score_gpt":0.532532651582271,"score_spread":0.23388375630929376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2851342260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007321272,0.99856406,0.000035002344,0.0009094707,0.00012588502,0.000007805045,0.00006252739,0.0000024083834,0.00021963472],"genre_scores_gemma":[0.00049483107,0.99879456,0.0001459071,0.00038639107,0.000085237145,0.000010424514,0.000037607373,8.356173e-7,0.000044128443],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99834204,0.00043673159,0.0005869349,0.00016462323,0.000387998,0.00008168286],"domain_scores_gemma":[0.993034,0.004977731,0.00095215987,0.00006871876,0.00078958995,0.00017779536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036862954,0.00080052856,0.0025811165,0.004842594,0.00060336135,0.0020498936,0.0015485657,0.0014726964,0.0052330643],"category_scores_gemma":[0.009973273,0.00044305605,0.0017784263,0.005786459,0.0007669159,0.0025045017,0.00140336,0.0019132494,0.00064565387],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001386064,0.00006936697,0.0010981961,0.23210838,0.00067394966,0.00014434573,0.0003133876,0.00024278402,0.000221134,0.0029179542,0.04247881,0.7195931],"study_design_scores_gemma":[0.00006606732,0.00011238654,0.0037987637,0.3519933,0.0026613758,0.00087738497,0.0007869818,0.00014049577,0.00017839436,0.0024592138,0.63686657,0.00005913443],"about_ca_topic_score_codex":0.005101016,"about_ca_topic_score_gemma":0.01633392,"teacher_disagreement_score":0.0052330643,"about_ca_system_score_codex":0.0018695001,"about_ca_system_score_gemma":0.00792292,"threshold_uncertainty_score":0.01949519},"labels":[],"label_agreement":null},{"id":"W2890928464","doi":"10.1007/s11864-018-0569-2","title":"Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Methotrexate; Diffuse large B-cell lymphoma; Chemotherapy; Internal medicine; Oncology; Lymphoma; Central nervous system; CHOP","score_opus":0.06791264979052666,"score_gpt":0.39285534009087036,"score_spread":0.32494269030034373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890928464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008333325,0.99934345,0.000045860907,0.00013757571,0.00007147156,0.0000025074248,0.000010005939,0.0000022984816,0.00030346154],"genre_scores_gemma":[0.0010112624,0.9982565,0.00015098225,0.00027345744,0.00013821785,0.00000430992,0.00002195565,7.947575e-7,0.00014243479],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998066,0.000040403494,0.000052932366,0.000031830965,0.00005121064,0.00001697959],"domain_scores_gemma":[0.99952185,0.00030588685,0.00007992727,0.000008103151,0.00006514254,0.000019083172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005392467,0.0005017464,0.0012733708,0.0013780949,0.00020456269,0.0010008119,0.0007566304,0.0007638202,0.0033724701],"category_scores_gemma":[0.0014658413,0.0002263079,0.0006430347,0.0010993598,0.0003097278,0.00096868904,0.00048078023,0.001443947,0.00064297346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009836032,0.0000655466,0.00040545998,0.034544874,0.00021721469,0.00021384198,0.000057089306,0.0003312803,0.00058221986,0.0015286739,0.017608851,0.9443466],"study_design_scores_gemma":[0.00013538232,0.0002506621,0.0030460702,0.03557994,0.0015992271,0.0037096736,0.00015061564,0.0002609423,0.0005259615,0.00297368,0.9517238,0.00004402377],"about_ca_topic_score_codex":0.0013075455,"about_ca_topic_score_gemma":0.00298949,"teacher_disagreement_score":0.0033724701,"about_ca_system_score_codex":0.00044207077,"about_ca_system_score_gemma":0.001134725,"threshold_uncertainty_score":0.011282027},"labels":[],"label_agreement":null},{"id":"W2917387482","doi":"10.1007/s11864-019-0617-6","title":"The Role of Angiogenesis Inhibitors in the Era of Immune Checkpoint Inhibitors and Targeted Therapy in Metastatic Non-Small Cell Lung Cancer","year":2019,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Medicine; Bevacizumab; Oncology; Lung cancer; Atezolizumab; Anaplastic lymphoma kinase; Internal medicine; Population; Combination therapy; Targeted therapy; Chemotherapy; Maintenance therapy; Epidermal growth factor receptor; Immunotherapy; Cancer; Pembrolizumab; Cancer research","score_opus":0.04126358621587533,"score_gpt":0.4020381611712739,"score_spread":0.36077457495539855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917387482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063109655,0.99909484,0.000055870478,0.00022731948,0.0001302255,0.000002839432,0.000016496298,0.000003829136,0.0004054163],"genre_scores_gemma":[0.0004806904,0.9986565,0.00011261041,0.0003143645,0.00014730441,0.0000040403634,0.000025836103,0.0000011387569,0.00025745996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997737,0.000045409262,0.00003408081,0.00003411206,0.00008521394,0.000027561082],"domain_scores_gemma":[0.99947125,0.0003071262,0.000078944344,0.000009678096,0.000097400734,0.000035589655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085577095,0.00063773897,0.0017220458,0.0015317694,0.00018450253,0.0011982374,0.00085028296,0.0010623706,0.0037882528],"category_scores_gemma":[0.0012088312,0.00023133654,0.0007915044,0.0015228246,0.00036610063,0.0013285776,0.0006071048,0.0025689956,0.0012407824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016820902,0.00006704019,0.00010994847,0.01699057,0.00015727538,0.00010852637,0.000030024976,0.00039089262,0.0009828347,0.0025773575,0.027648011,0.9507693],"study_design_scores_gemma":[0.000120736455,0.00025144257,0.000846185,0.0073188758,0.00045449848,0.0007391732,0.000040157556,0.00021522246,0.00041808994,0.0023223276,0.98724735,0.000026015246],"about_ca_topic_score_codex":0.00092773495,"about_ca_topic_score_gemma":0.002665144,"teacher_disagreement_score":0.0037882528,"about_ca_system_score_codex":0.00057491055,"about_ca_system_score_gemma":0.001016002,"threshold_uncertainty_score":0.01267302},"labels":[],"label_agreement":null},{"id":"W2922298974","doi":"10.1007/s11864-019-0623-8","title":"Role of Bisphosphonates in Breast Cancer Therapy","year":2019,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Zoledronic acid; Bisphosphonate; Breast cancer; Osteonecrosis of the jaw; Adverse effect; Internal medicine; Oncology; Metastatic breast cancer; Adjuvant therapy; Cancer; Osteoporosis","score_opus":0.13250052695148004,"score_gpt":0.483185934135227,"score_spread":0.35068540718374697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922298974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033216962,0.99930084,0.00003469888,0.00012640141,0.000084281826,0.0000022226977,0.000011127987,0.0000029975,0.00040423573],"genre_scores_gemma":[0.00027202533,0.99919015,0.00009008826,0.00015615427,0.0000930883,0.000002385325,0.000014068084,6.3417474e-7,0.00018140244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996499,0.00006725247,0.00007441061,0.00005681954,0.00012135392,0.000030403044],"domain_scores_gemma":[0.9992465,0.00044491532,0.00012546164,0.000016634865,0.0001303484,0.00003621937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091128255,0.00089594384,0.0021099076,0.0030927309,0.00029619422,0.0014767126,0.001016521,0.0013272036,0.0062175556],"category_scores_gemma":[0.001592446,0.00036345996,0.0008485144,0.0030825327,0.00052868976,0.0012676868,0.0008188604,0.002351241,0.0018083776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013090558,0.00008299165,0.0001443988,0.029557263,0.00016731967,0.00010467183,0.000036189493,0.0003404641,0.0006973456,0.0022509603,0.016515655,0.9499719],"study_design_scores_gemma":[0.00009449488,0.00019837442,0.0010694957,0.016301952,0.00071955303,0.00096163683,0.00007109818,0.0001824432,0.00034487314,0.0020774822,0.9779499,0.000028591681],"about_ca_topic_score_codex":0.0022349705,"about_ca_topic_score_gemma":0.0045035784,"teacher_disagreement_score":0.0062175556,"about_ca_system_score_codex":0.0008076505,"about_ca_system_score_gemma":0.0017706495,"threshold_uncertainty_score":0.020799816},"labels":[],"label_agreement":null},{"id":"W3005822748","doi":"10.1007/s11864-020-0716-4","title":"Evolving Definitions of Palliative Care: Upstream Migration or Confusion?","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Palliative care; Medicine; CLARITY; Specialty; Nursing; End-of-life care; Intervention (counseling); Relevance (law); Health care; Confusion; Meaning (existential); Multitude; Family medicine; Psychology; Economic growth; Psychotherapist; Political science","score_opus":0.5197124836064386,"score_gpt":0.5557968442633401,"score_spread":0.03608436065690146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005822748","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058680725,0.9793858,0.00043605216,0.016726097,0.0021232818,0.000005800529,0.000015097343,0.0000072255625,0.0012419085],"genre_scores_gemma":[0.001743257,0.97733897,0.0014301224,0.01610489,0.002878615,0.00003217053,0.000039865154,0.000013615288,0.00041846928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943394,0.0029851848,0.000912621,0.00048488934,0.0009814226,0.000296491],"domain_scores_gemma":[0.9785096,0.015347267,0.0013330216,0.00044129003,0.0035538834,0.00081488775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015794653,0.0013566194,0.004290098,0.005031127,0.0014963085,0.008360968,0.0046393615,0.0053905924,0.0057866597],"category_scores_gemma":[0.023368372,0.000757005,0.0014107192,0.007253144,0.011213637,0.017538825,0.0050638793,0.015885,0.0023124437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009032841,0.00006102502,0.0004191156,0.030963857,0.00015478258,0.00019100726,0.0025369688,0.0003395202,0.00017752648,0.16763768,0.09725201,0.7001761],"study_design_scores_gemma":[0.0000311928,0.000043732576,0.0005467727,0.066337354,0.00013097988,0.00058378564,0.0022734646,0.00017363355,0.000044463224,0.049730558,0.88004047,0.00006353017],"about_ca_topic_score_codex":0.005569732,"about_ca_topic_score_gemma":0.013430017,"teacher_disagreement_score":0.015794653,"about_ca_system_score_codex":0.0059047933,"about_ca_system_score_gemma":0.0147353355,"threshold_uncertainty_score":0.08353108},"labels":[],"label_agreement":null},{"id":"W3012199532","doi":"10.1007/s11864-020-0725-3","title":"Curative-Intent Therapies in Localized Hepatocellular Carcinoma","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Liver transplantation; Embolization; Percutaneous; Milan criteria; Curative treatment; Cirrhosis; Radiology; Surgery; Transplantation; Ablation; Internal medicine; Disease","score_opus":0.27316647235241404,"score_gpt":0.41223359950954547,"score_spread":0.13906712715713143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012199532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000073211166,0.99931633,0.00004618916,0.000104044324,0.00006351131,0.0000030014855,0.000012396588,0.000002812888,0.00037851348],"genre_scores_gemma":[0.00058866246,0.9989128,0.00008321819,0.00015781182,0.0000775937,0.000003853133,0.000022313765,7.784192e-7,0.00015300592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998622,0.000035276717,0.000029254013,0.000023411223,0.000037079062,0.000012874658],"domain_scores_gemma":[0.99967504,0.00018940774,0.00006974224,0.000007417091,0.000041190917,0.000017191198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058361015,0.0005925812,0.0017089718,0.0014294807,0.00014433374,0.00082445465,0.00058504066,0.0005992714,0.003475957],"category_scores_gemma":[0.0009131978,0.00022973573,0.0006561705,0.0016462597,0.00029007482,0.0009052744,0.00048085998,0.0012073301,0.0009059332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013404377,0.000048264228,0.0001619962,0.031595208,0.00019518122,0.000079110425,0.00003413759,0.00039144148,0.0006144304,0.0010708439,0.015165855,0.9505093],"study_design_scores_gemma":[0.00020379404,0.00041480752,0.0025883378,0.027984463,0.0015728028,0.0014182758,0.000097114,0.00039695678,0.00051302166,0.0025626682,0.96220165,0.000046116325],"about_ca_topic_score_codex":0.001013556,"about_ca_topic_score_gemma":0.0028371937,"teacher_disagreement_score":0.003475957,"about_ca_system_score_codex":0.0005023343,"about_ca_system_score_gemma":0.0007749925,"threshold_uncertainty_score":0.01162827},"labels":[],"label_agreement":null},{"id":"W3023432596","doi":"10.1007/s11864-020-00746-8","title":"PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Idelalisib; Medicine; PI3K/AKT/mTOR pathway; Adverse effect; Lymphoma; Clinical trial; Targeted therapy; Oncology; Cancer research; Pharmacology; Immunology; Internal medicine; Cancer; Signal transduction; Chronic lymphocytic leukemia; Ibrutinib; Leukemia; Biology","score_opus":0.14918485012211347,"score_gpt":0.45621544531539787,"score_spread":0.3070305951932844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023432596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010709933,0.9988072,0.000083390274,0.0002048561,0.00012829034,0.0000045585957,0.00002503842,0.000008460816,0.0006311354],"genre_scores_gemma":[0.0007481123,0.99821115,0.00015701578,0.00026886773,0.00013886834,0.0000066297275,0.00004764712,0.0000015228028,0.00042025687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998573,0.00002620385,0.000020137708,0.000023179176,0.00005134288,0.000021817934],"domain_scores_gemma":[0.99976236,0.00012360518,0.000038960472,0.0000057666753,0.000047867386,0.000021367601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006314549,0.0007740636,0.0016778606,0.0015106696,0.00017813775,0.0011089693,0.00082703785,0.00083258224,0.0049656793],"category_scores_gemma":[0.00069925655,0.0002388141,0.0006203259,0.0017914352,0.0003531156,0.0011340961,0.0005764818,0.002139115,0.0021321368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026566655,0.00008697146,0.000109901644,0.0126068145,0.00013888512,0.000112618356,0.000026056723,0.0004355892,0.0013259123,0.002269469,0.027310684,0.95531136],"study_design_scores_gemma":[0.00021266745,0.0003318967,0.0008270814,0.0038757038,0.00046196225,0.0007119542,0.00004084021,0.00027212256,0.00052687625,0.0025161167,0.99019617,0.000026536583],"about_ca_topic_score_codex":0.0009269548,"about_ca_topic_score_gemma":0.0022365693,"teacher_disagreement_score":0.0049656793,"about_ca_system_score_codex":0.00056461146,"about_ca_system_score_gemma":0.00084475667,"threshold_uncertainty_score":0.016611874},"labels":[],"label_agreement":null},{"id":"W3030067474","doi":"10.1007/s11864-020-00752-w","title":"Exercise Training for Cancer Survivors","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cardiotoxicity; Cardiorespiratory fitness; Cancer; Rehabilitation; Survivorship curve; Cancer survivorship; Cancer therapy; Physical therapy; Intensive care medicine; Cancer treatment; Internal medicine; Chemotherapy","score_opus":0.2963883370487826,"score_gpt":0.49759753185333033,"score_spread":0.20120919480454774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030067474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014838183,0.99915254,0.000029684972,0.00013280455,0.00010308885,0.0000057244138,0.000015594664,0.0000026352916,0.0004095036],"genre_scores_gemma":[0.0013014721,0.99773115,0.00010677236,0.0002837128,0.00016292708,0.0000138791565,0.000028218186,0.000001120386,0.00037076318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988127,0.000026022037,0.000023012379,0.000028981382,0.000026711812,0.000013975041],"domain_scores_gemma":[0.99974173,0.00015686858,0.00004951572,0.0000058967007,0.000029676457,0.000016306609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004823934,0.0007827496,0.001471966,0.0011156321,0.00022650736,0.00076637644,0.00062314776,0.001143424,0.006196865],"category_scores_gemma":[0.00093334535,0.00024290911,0.00094504893,0.0008935746,0.00024327227,0.0005214712,0.0005962944,0.0017463022,0.00095681293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024343736,0.00017702796,0.00021092879,0.03780821,0.00031326438,0.00004782288,0.000035380075,0.00018973555,0.00044099483,0.0006864107,0.0108517315,0.9489951],"study_design_scores_gemma":[0.0009479356,0.001489838,0.010892869,0.13507159,0.0041169906,0.001256666,0.0002808122,0.0004263299,0.00074711913,0.003821044,0.84087884,0.000070088456],"about_ca_topic_score_codex":0.0019021273,"about_ca_topic_score_gemma":0.0039804927,"teacher_disagreement_score":0.006196865,"about_ca_system_score_codex":0.00029296838,"about_ca_system_score_gemma":0.00079378806,"threshold_uncertainty_score":0.020730555},"labels":[],"label_agreement":null},{"id":"W3034194717","doi":"10.1007/s11864-020-00748-6","title":"Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"SABR volatility model; Medicine; Radiation therapy; Ablative case; Gynecologic cancer; Endometrial cancer; Cancer; Oncology; Radiology; Internal medicine; Surgery; Ovarian cancer","score_opus":0.31633104907775855,"score_gpt":0.5337077434769574,"score_spread":0.21737669439919882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034194717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045770226,0.99926585,0.00002739636,0.00019599724,0.000097958306,0.0000019400404,0.000009223888,0.0000025131717,0.0003534428],"genre_scores_gemma":[0.00035589142,0.99906,0.00006958636,0.00021522165,0.00010213171,0.000002611546,0.000015475149,8.0306563e-7,0.00017830236],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998098,0.000043822893,0.000027763657,0.000028817207,0.00006770233,0.000022121822],"domain_scores_gemma":[0.9996797,0.00016843654,0.00006339846,0.0000057460297,0.00006198763,0.00002073037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069197104,0.00068144704,0.0016770628,0.0015195061,0.00022119211,0.0010662026,0.0010367221,0.0010328429,0.0051239287],"category_scores_gemma":[0.000967173,0.00023455298,0.00062354637,0.0017959841,0.0004600039,0.001175714,0.0005279278,0.0018705799,0.0015725228],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102088656,0.000042513642,0.0001361676,0.023198234,0.00014279335,0.0000916613,0.000047289148,0.0002312991,0.00052180036,0.0018642826,0.029750336,0.9438715],"study_design_scores_gemma":[0.00012457262,0.00020723876,0.0012938448,0.020201439,0.0006419073,0.001274336,0.00013752609,0.00016809553,0.00019470563,0.0024361962,0.97328657,0.000033703596],"about_ca_topic_score_codex":0.0020246126,"about_ca_topic_score_gemma":0.0064050225,"teacher_disagreement_score":0.0051239287,"about_ca_system_score_codex":0.0006562709,"about_ca_system_score_gemma":0.0011161679,"threshold_uncertainty_score":0.017141283},"labels":[],"label_agreement":null},{"id":"W3128995505","doi":"10.1007/s11864-021-00817-4","title":"Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?","year":2021,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Neuroendocrine tumors; Intensive care medicine; Clinical trial; Immunotherapy; Regimen; Cancer; Lung cancer; Oncology; Internal medicine","score_opus":0.13494388790928052,"score_gpt":0.4794337252712568,"score_spread":0.3444898373619763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128995505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048272737,0.99863714,0.0000725434,0.0004919287,0.00028994292,0.000002492825,0.000011027353,0.000005119566,0.00044150767],"genre_scores_gemma":[0.00042618613,0.99809366,0.00014093709,0.0005168036,0.00041558486,0.000004716303,0.000023472605,0.0000013731718,0.000377201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998098,0.000045471184,0.000025428622,0.00002798795,0.00006456407,0.000026749085],"domain_scores_gemma":[0.9995447,0.00024550562,0.000055338554,0.000011470992,0.00009980747,0.000043122578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008481131,0.0006852004,0.0017147477,0.0011016993,0.0002181599,0.0013532129,0.00081598974,0.0011425284,0.0040607816],"category_scores_gemma":[0.0012086723,0.00021747268,0.0005947151,0.0011717193,0.00040503248,0.0016615711,0.0006065851,0.0027468016,0.0019170912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011552489,0.00005606823,0.00015404956,0.009623935,0.00008289161,0.00011101521,0.000025988402,0.00039980744,0.000803287,0.001827079,0.04539518,0.94140524],"study_design_scores_gemma":[0.00008433889,0.00015512045,0.00070935354,0.0074592503,0.00023057862,0.00083840615,0.000058139332,0.00019187802,0.00024951092,0.0024970435,0.9875049,0.0000214492],"about_ca_topic_score_codex":0.00085047213,"about_ca_topic_score_gemma":0.0022165142,"teacher_disagreement_score":0.0040607816,"about_ca_system_score_codex":0.0005412246,"about_ca_system_score_gemma":0.0010169438,"threshold_uncertainty_score":0.013584673},"labels":[],"label_agreement":null},{"id":"W3140031112","doi":"10.1007/s11864-021-00836-1","title":"Models of Integration of Specialized Palliative Care with Oncology","year":2021,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Department of Medicine, University of Toronto; University of Toronto","keywords":"Medicine; Palliative care; Referral; Ambulatory care; Randomized controlled trial; Quality of life (healthcare); Intensive care medicine; Nursing; Family medicine; Health care; Internal medicine","score_opus":0.5283865048148864,"score_gpt":0.581279279842736,"score_spread":0.052892775027849614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140031112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013633918,0.9942252,0.0004090154,0.0014033488,0.00019117312,0.000013650303,0.000012352267,0.000006255587,0.0036027443],"genre_scores_gemma":[0.0018897143,0.9958068,0.0008311267,0.0007927849,0.0001393251,0.00002177373,0.00002097961,0.0000015422308,0.0004960386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992348,0.00034382037,0.000081323626,0.000089574736,0.00019326365,0.000057274712],"domain_scores_gemma":[0.99848664,0.001052082,0.00017404235,0.000032404365,0.00018634606,0.00006844804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023198086,0.0008850974,0.0011594623,0.002288916,0.00047568037,0.0029040137,0.0016926652,0.0017494889,0.004632967],"category_scores_gemma":[0.0026252437,0.0002760089,0.0008509917,0.0028240439,0.0016522723,0.0031689934,0.0016706995,0.0028411383,0.0012280722],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061034814,0.00008459044,0.00030245748,0.03567371,0.00014570284,0.000120819204,0.00043190503,0.0009094256,0.00025081684,0.11306566,0.017244063,0.83170986],"study_design_scores_gemma":[0.00002609521,0.00007187179,0.0010135575,0.04492317,0.00021981589,0.000738188,0.0003997804,0.00032061813,0.000114262046,0.02263865,0.9295068,0.00002733211],"about_ca_topic_score_codex":0.003364001,"about_ca_topic_score_gemma":0.007247072,"teacher_disagreement_score":0.004632967,"about_ca_system_score_codex":0.003430067,"about_ca_system_score_gemma":0.004875561,"threshold_uncertainty_score":0.024887025},"labels":[],"label_agreement":null},{"id":"W3169098949","doi":"10.1007/s11864-021-00856-x","title":"Current Management of Chronic Neutrophilic Leukemia","year":2021,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Ruxolitinib; Dasatinib; Oncology; Clinical trial; Internal medicine; Myelofibrosis; Imatinib; Immunology; Bone marrow; Myeloid leukemia","score_opus":0.1147755261590812,"score_gpt":0.4451971280526817,"score_spread":0.3304216018936005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169098949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004705198,0.9989188,0.00006841369,0.00021446373,0.0001288083,0.000004278801,0.000015879945,0.0000047246517,0.0005975887],"genre_scores_gemma":[0.0004077002,0.9986777,0.00015847725,0.0002831423,0.00017204546,0.000005557536,0.000033074648,9.360767e-7,0.00026134736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977475,0.00005200254,0.000043194912,0.000031721287,0.00007635368,0.00002193716],"domain_scores_gemma":[0.99957615,0.00022060418,0.00008261698,0.000008046933,0.00008255594,0.000030041865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000593183,0.00063534075,0.0014434713,0.0015397267,0.00022903344,0.0011046659,0.0007958505,0.00072500604,0.0048124674],"category_scores_gemma":[0.0012343733,0.00021050479,0.0006310753,0.0013861972,0.0003123477,0.0009599518,0.0005885849,0.0016504603,0.0014770714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010003403,0.00004669144,0.00014081386,0.01939871,0.0000904064,0.000083417355,0.000025089968,0.00024121367,0.00039064558,0.0014533123,0.024977142,0.9530525],"study_design_scores_gemma":[0.000083427854,0.00013258675,0.00094959704,0.01696626,0.00044645602,0.0009421376,0.000058126338,0.00014556531,0.00021833651,0.0019887968,0.9780477,0.00002093149],"about_ca_topic_score_codex":0.0013070176,"about_ca_topic_score_gemma":0.0029760015,"teacher_disagreement_score":0.0048124674,"about_ca_system_score_codex":0.00054201443,"about_ca_system_score_gemma":0.0012402347,"threshold_uncertainty_score":0.016099334},"labels":[],"label_agreement":null},{"id":"W3172328329","doi":"10.1007/s11864-021-00854-z","title":"Radiation Necrosis from Stereotactic Radiosurgery—How Do We Mitigate?","year":2021,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; Bevacizumab; Radiation therapy; Medical physics; Radiology; Surgery; Chemotherapy","score_opus":0.14548806542247372,"score_gpt":0.43391227758448064,"score_spread":0.2884242121620069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172328329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003384809,0.9990038,0.000039063907,0.00046543486,0.00015295437,0.0000014181368,0.000008789274,0.000003095591,0.00029160592],"genre_scores_gemma":[0.00043981906,0.99866235,0.00009164335,0.00039779878,0.00022806798,0.0000030804758,0.000013226912,0.0000011959979,0.00016285284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996619,0.00008405506,0.00006361415,0.000060279064,0.000095499156,0.000034602184],"domain_scores_gemma":[0.9991761,0.00044671126,0.00015376825,0.000018751449,0.00015705038,0.00004758841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013067567,0.00089492253,0.0021549996,0.0018090087,0.00028641793,0.0018449815,0.0011912636,0.0015156311,0.0045575867],"category_scores_gemma":[0.0019892827,0.0003233409,0.0009182937,0.0015666576,0.0007830324,0.002313195,0.0006969971,0.0026114315,0.0016558801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011833029,0.000051401486,0.00021872282,0.024639677,0.00018130337,0.000112698006,0.000046027635,0.0003134554,0.00053271337,0.0042501744,0.03576249,0.93377304],"study_design_scores_gemma":[0.00007736628,0.00018592583,0.0013455591,0.02316629,0.00062326697,0.0013638448,0.00013916745,0.00020549107,0.00034464055,0.005382085,0.9671231,0.000043364216],"about_ca_topic_score_codex":0.0024194669,"about_ca_topic_score_gemma":0.0057647135,"teacher_disagreement_score":0.0045575867,"about_ca_system_score_codex":0.0010749712,"about_ca_system_score_gemma":0.0021991974,"threshold_uncertainty_score":0.01524663},"labels":[],"label_agreement":null},{"id":"W3188859885","doi":"10.1007/s11864-003-0006-y","title":"Insulinoma","year":2003,"lang":"en","type":"article","venue":"Current Treatment Options in Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Insulinoma; Enucleation; Palpation; Multiple endocrine neoplasia; Gold standard (test); Sunitinib; Pancreas; Radiology; Surgery; Cancer; Internal medicine","score_opus":0.09310704355213165,"score_gpt":0.44480105338771364,"score_spread":0.35169400983558197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188859885","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2652844,0.032704383,0.01359925,0.010029401,0.004298746,0.00024918304,0.0014157601,0.0015259138,0.670893],"genre_scores_gemma":[0.7565113,0.012948986,0.0059850947,0.006921221,0.0012354358,0.00012737967,0.0018924505,0.00020658928,0.21417153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998672,0.000011643361,0.000010506739,0.00004046155,0.0000314467,0.000038720773],"domain_scores_gemma":[0.9998022,0.00003132831,0.000025165444,0.000038839895,0.00003372416,0.00006877806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019219212,0.00036073395,0.0002835985,0.000651665,0.0005694171,0.000883542,0.000319294,0.00057279604,0.023199955],"category_scores_gemma":[0.0006063834,0.000114086804,0.00046816026,0.0005647073,0.00032355124,0.0005414191,0.0005398055,0.0011354424,0.009457238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002686455,0.0007495612,0.029529791,0.00061471487,0.00017359213,0.10024397,0.0003758777,0.00033232704,0.103594884,0.015256236,0.04462528,0.70181733],"study_design_scores_gemma":[0.0002578028,0.0009079368,0.02175578,0.0002609391,0.00020491026,0.2980801,0.00037416586,0.0005805306,0.03869168,0.005143098,0.633701,0.000041959276],"about_ca_topic_score_codex":0.0005230281,"about_ca_topic_score_gemma":0.0004970571,"teacher_disagreement_score":0.023199955,"about_ca_system_score_codex":0.0005278199,"about_ca_system_score_gemma":0.00037504922,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W3191985722","doi":"10.1007/s11864-002-0031-2","title":"Carcinoid tumors","year":2002,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Lanreotide; Carcinoid syndrome; Octreotide; Carcinoid Heart Disease; Carcinoid tumors; Neuroendocrine tumors; Somatostatin; Metastasis; Endocrine system; Gastroenterology; Internal medicine; Surgery; Cancer; Pathology; Hormone; Acromegaly","score_opus":0.21478441182762414,"score_gpt":0.49814648917972876,"score_spread":0.2833620773521046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191985722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004826233,0.99307585,0.00045188624,0.00044678754,0.0005665224,0.000009167449,0.000027205315,0.000020642052,0.0049194675],"genre_scores_gemma":[0.0031698614,0.9888707,0.0006075063,0.00062068435,0.00064985966,0.000011101678,0.00008585788,0.0000041484495,0.005980357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990475,0.000011988439,0.000013897499,0.000019994583,0.00003724726,0.000012092794],"domain_scores_gemma":[0.99986756,0.000048387512,0.00002644838,0.000008026688,0.000032187843,0.00001739059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002501894,0.0006793448,0.0009741755,0.0016439189,0.00024516674,0.0006895291,0.00046553338,0.0006308768,0.0049854335],"category_scores_gemma":[0.0004472528,0.00017813977,0.0002943251,0.0015327863,0.00029809598,0.0010965905,0.00046083162,0.00095366174,0.0030873504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052146217,0.000031673917,0.00025098497,0.002676757,0.000022531825,0.0009594729,0.000022468954,0.00016589332,0.001562923,0.0007356731,0.023680652,0.9698388],"study_design_scores_gemma":[0.000024534213,0.00007070264,0.0011054531,0.0013546644,0.00009943712,0.011521067,0.000046599776,0.00009003732,0.00094189093,0.0006471858,0.9840875,0.000010949653],"about_ca_topic_score_codex":0.00087989337,"about_ca_topic_score_gemma":0.0024272995,"teacher_disagreement_score":0.0049854335,"about_ca_system_score_codex":0.00040593004,"about_ca_system_score_gemma":0.0007324105,"threshold_uncertainty_score":0.016677916},"labels":[],"label_agreement":null},{"id":"W4212810560","doi":"10.1007/s11864-021-00929-x","title":"Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Terry Fox Research Institute","keywords":"Immunoediting; Immunosurveillance; Tumor microenvironment; Immune system; Immunotherapy; Medicine; Ovarian cancer; Myeloid-derived Suppressor Cell; Natural killer cell; Cancer research; Immunology; Cancer; Biology; Cytotoxic T cell; Internal medicine; Suppressor","score_opus":0.07730971623990514,"score_gpt":0.37313948212203113,"score_spread":0.295829765882126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212810560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004866018,0.99895084,0.00007119501,0.0003079791,0.00030743683,0.0000021661908,0.000010817813,0.0000044712724,0.00029642475],"genre_scores_gemma":[0.00043396172,0.9983492,0.00009793772,0.0003427586,0.00037401955,0.000003515358,0.00002522359,0.0000011897504,0.00037218566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998172,0.000035273642,0.000025053201,0.000028076565,0.00007251535,0.00002194868],"domain_scores_gemma":[0.99965656,0.00017568524,0.00004391235,0.0000074945915,0.00007973657,0.000036738078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065079884,0.00072255434,0.0016566009,0.0010485622,0.00018794593,0.0011071682,0.0008644591,0.0010717497,0.0032561866],"category_scores_gemma":[0.0008868394,0.00020801632,0.00038567718,0.0010402234,0.0004850386,0.0012737687,0.00063656754,0.0029022165,0.002006776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001383494,0.000055204524,0.00009860378,0.008863937,0.00006253296,0.00011202646,0.000019692998,0.00024874407,0.0008871523,0.0021637748,0.043412797,0.9439371],"study_design_scores_gemma":[0.000079736186,0.00017415917,0.0007193534,0.004084107,0.00015841247,0.00089335174,0.00004765617,0.00015507065,0.00032003643,0.0021395606,0.99120754,0.000021044008],"about_ca_topic_score_codex":0.00066635263,"about_ca_topic_score_gemma":0.0016009825,"teacher_disagreement_score":0.0032561866,"about_ca_system_score_codex":0.00045927856,"about_ca_system_score_gemma":0.00077437493,"threshold_uncertainty_score":0.010892987},"labels":[],"label_agreement":null},{"id":"W4229037395","doi":"10.1007/s11864-022-00988-8","title":"Immune Checkpoint Inhibitors for the Treatment of Gestational Trophoblastic Neoplasia: Rationale, Effectiveness, and Future Fertility","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Gestational trophoblastic neoplasia; Gestational trophoblastic disease; Oncology; Chemotherapy; Disease; Adverse effect; Internal medicine; Clinical trial; Pregnancy; Intensive care medicine; Gynecology; Gestation","score_opus":0.07089288282692768,"score_gpt":0.39336930976956347,"score_spread":0.3224764269426358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229037395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059469272,0.99956936,0.000023767356,0.00013970796,0.000051057814,0.0000028604602,0.000013353058,0.0000015117273,0.0001389568],"genre_scores_gemma":[0.0005772925,0.99901104,0.0000835816,0.00015652193,0.000054582077,0.000005493276,0.000018441815,5.119727e-7,0.00009242318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974614,0.000082469094,0.000044989512,0.00003611287,0.000068813766,0.000021528476],"domain_scores_gemma":[0.99914896,0.00061199797,0.00010708215,0.000012319633,0.00009162271,0.000028053035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010610617,0.00062424655,0.0022758036,0.0014123316,0.00018178814,0.0009714909,0.0009359679,0.0009028655,0.0040763994],"category_scores_gemma":[0.001769464,0.00020373405,0.001168915,0.0013960147,0.00033652663,0.00076152646,0.0004373705,0.0017721655,0.0006902392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046589554,0.00008024678,0.00018356166,0.05631919,0.00071956386,0.00011674056,0.000036737827,0.000327186,0.0008491465,0.0023074513,0.014252754,0.9243416],"study_design_scores_gemma":[0.00066560484,0.000766901,0.0023129846,0.05249515,0.0039147385,0.0014836766,0.00013576479,0.0002642762,0.000971268,0.003937462,0.9329938,0.000058364647],"about_ca_topic_score_codex":0.0012926094,"about_ca_topic_score_gemma":0.003398831,"teacher_disagreement_score":0.0040763994,"about_ca_system_score_codex":0.0005102115,"about_ca_system_score_gemma":0.0012500284,"threshold_uncertainty_score":0.013636887},"labels":[],"label_agreement":null},{"id":"W4283827551","doi":"10.1007/s11864-022-00993-x","title":"Incorporating Molecular Diagnostics into Treatment Paradigms for Endometrial Cancer","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Endometrial cancer; Oncology; Lenvatinib; Internal medicine; DNA mismatch repair; Trastuzumab; Population; Adjuvant; Cancer; Cancer research; Immunotherapy; Thyroid cancer; Breast cancer","score_opus":0.22744445458158166,"score_gpt":0.4979339040913149,"score_spread":0.2704894495097332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283827551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000566078,0.99869907,0.000099960984,0.00029445242,0.00014996078,0.000005425331,0.000015485617,0.000004773093,0.0006742786],"genre_scores_gemma":[0.00051002967,0.99851125,0.00020237762,0.00033999723,0.00012663646,0.0000053083927,0.000023685163,0.0000010591564,0.00027961505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998067,0.000050401504,0.000030996496,0.00003307092,0.000057901678,0.000020986501],"domain_scores_gemma":[0.99953043,0.0003141877,0.00005060264,0.00001071476,0.00007344015,0.000020611054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000846995,0.0007073015,0.001257731,0.0014836731,0.00021294196,0.0011151339,0.00069410104,0.0009579289,0.0052165366],"category_scores_gemma":[0.0014354016,0.00025623548,0.00070260616,0.0011738216,0.00042133528,0.0011751378,0.0006616804,0.0021411353,0.0014522569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011619266,0.00006368096,0.00012870999,0.022866312,0.00012465428,0.000105796134,0.00003962228,0.00033379995,0.0011096004,0.003360683,0.018294742,0.9534562],"study_design_scores_gemma":[0.00008329608,0.00021265895,0.0007868431,0.013754706,0.0004953163,0.00065143156,0.00007284334,0.00018910457,0.0005504538,0.0034028664,0.9797752,0.000025179026],"about_ca_topic_score_codex":0.0012406814,"about_ca_topic_score_gemma":0.0029308426,"teacher_disagreement_score":0.0052165366,"about_ca_system_score_codex":0.00056959264,"about_ca_system_score_gemma":0.0012724093,"threshold_uncertainty_score":0.017451048},"labels":[],"label_agreement":null},{"id":"W4291202004","doi":"10.1007/s11864-022-01009-4","title":"Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Canada Research Chairs; University Health Network","funders":"","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Urothelial cancer; Targeted therapy; Precision medicine; Fibroblast growth factor receptor; Oncology; Dosing; Immunotherapy; Cancer research; Internal medicine; Cancer; Chemotherapy; Bladder cancer; Fibroblast growth factor; Pathology","score_opus":0.09544036010765244,"score_gpt":0.401192488017979,"score_spread":0.3057521279103266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291202004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012761676,0.99810743,0.0001254321,0.0006794787,0.00024012245,0.000003225877,0.000025134983,0.000010722183,0.00068077527],"genre_scores_gemma":[0.0008540731,0.99771464,0.00018934431,0.0004815666,0.00017619939,0.000003968935,0.000034237877,0.0000015068141,0.00054449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987423,0.000025124045,0.000014031633,0.000022494689,0.000046047946,0.000018008557],"domain_scores_gemma":[0.9997081,0.00014465045,0.000038499336,0.000006609994,0.000075766366,0.000026298321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006003595,0.0006012142,0.0012506065,0.0008425372,0.0001646594,0.0010857788,0.0006492813,0.000959448,0.005650256],"category_scores_gemma":[0.00069273904,0.00015452257,0.00061838794,0.00086603465,0.0003508026,0.0013794275,0.00047441857,0.002038498,0.0016993895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012699368,0.00006501728,0.00011622052,0.010990313,0.000085121486,0.00010011987,0.00002917561,0.0003797421,0.0018381508,0.002177521,0.02919456,0.95489705],"study_design_scores_gemma":[0.00006202914,0.00021515008,0.0007044858,0.0040222625,0.0002659494,0.000587686,0.00006817404,0.00019921902,0.0003987503,0.0022516882,0.9912004,0.000024275907],"about_ca_topic_score_codex":0.001263602,"about_ca_topic_score_gemma":0.0035754866,"teacher_disagreement_score":0.005650256,"about_ca_system_score_codex":0.0004498486,"about_ca_system_score_gemma":0.0010339007,"threshold_uncertainty_score":0.018902004},"labels":[],"label_agreement":null},{"id":"W4291891254","doi":"10.1007/s11864-022-01002-x","title":"Role of Stereotactic Radiation Therapy in Operable and Inoperable Early-Stage Non-small Cell Lung Cancer","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; Radiation therapy; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Radiology","score_opus":0.06807786759511557,"score_gpt":0.40799979988079693,"score_spread":0.33992193228568135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291891254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004039321,0.9994424,0.000031389543,0.00009356015,0.00006617404,0.0000021910143,0.0000130231865,0.0000021932929,0.0003087042],"genre_scores_gemma":[0.00032977114,0.99928325,0.00006576912,0.00010855124,0.000058357742,0.0000021576034,0.000019342226,6.301641e-7,0.00013216866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981624,0.000037877508,0.000034645967,0.000032546934,0.0000623788,0.00001632631],"domain_scores_gemma":[0.9996393,0.00020175111,0.00006727985,0.0000075697553,0.00006687109,0.000017177552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061070145,0.0006418659,0.0016171049,0.0018740151,0.00016805592,0.000929559,0.000787523,0.00072041055,0.003915949],"category_scores_gemma":[0.00096355146,0.00023783065,0.000798545,0.0018658274,0.00030670853,0.00092906394,0.0005168752,0.0013124576,0.0010307138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090978676,0.000041801544,0.00020550536,0.029650101,0.00020224521,0.000091584305,0.000036901594,0.00039185755,0.00062984,0.001332993,0.019235494,0.94809073],"study_design_scores_gemma":[0.000096779266,0.00021352919,0.002102,0.018259026,0.0009812044,0.0012512254,0.00007488913,0.00022712664,0.00038130005,0.0016389801,0.97473985,0.000034068722],"about_ca_topic_score_codex":0.0022484066,"about_ca_topic_score_gemma":0.004922261,"teacher_disagreement_score":0.003915949,"about_ca_system_score_codex":0.00064242916,"about_ca_system_score_gemma":0.0012755364,"threshold_uncertainty_score":0.013100088},"labels":[],"label_agreement":null},{"id":"W4323294209","doi":"10.1007/s11864-023-01059-2","title":"Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Soft tissue sarcoma; Chemoradiotherapy; Clinical trial; Chemotherapy; Sarcoma; Radiation therapy; Oncology; Internal medicine; Surgery; Soft tissue; Pathology","score_opus":0.20565851597800436,"score_gpt":0.4755904172331465,"score_spread":0.2699319012551421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323294209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000104568426,0.9989712,0.00006794936,0.00028118337,0.00012466765,0.0000023348875,0.000014754143,0.0000041818753,0.0004291105],"genre_scores_gemma":[0.00062357576,0.9986248,0.00010593587,0.00028506885,0.00010737306,0.0000028182883,0.00002318149,0.0000011223436,0.00022616232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998846,0.0000256866,0.000018371466,0.000022403674,0.00003434262,0.000014637167],"domain_scores_gemma":[0.99971586,0.0001473714,0.00005181646,0.0000061194755,0.000057037476,0.000021743212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005049788,0.0004847287,0.0014104008,0.0010177821,0.0001679827,0.0009395297,0.0007108434,0.0006287142,0.0042956704],"category_scores_gemma":[0.00072317227,0.0001701746,0.00058161555,0.0011430929,0.00031770198,0.0011267649,0.00042909558,0.001470639,0.0013517914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010566888,0.00004413706,0.00012058332,0.01592842,0.000107448446,0.000080863756,0.000026811385,0.00029109884,0.0006492271,0.0011529971,0.021400362,0.9600924],"study_design_scores_gemma":[0.00012582618,0.00028595122,0.0016857011,0.019344874,0.000705481,0.0016375674,0.00010572632,0.000291066,0.00043449664,0.0027350974,0.97260994,0.000038271603],"about_ca_topic_score_codex":0.0010804064,"about_ca_topic_score_gemma":0.003282231,"teacher_disagreement_score":0.0042956704,"about_ca_system_score_codex":0.00041263702,"about_ca_system_score_gemma":0.0008289527,"threshold_uncertainty_score":0.014370441},"labels":[],"label_agreement":null},{"id":"W4324017998","doi":"10.1007/s11864-023-01060-9","title":"Integrating Palliative Care into Oncology Care Worldwide: The Right Care in the Right Place at the Right Time","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network","funders":"","keywords":"Palliative care; Medicine; Context (archaeology); Nursing; Ambulatory care; End-of-life care; Point of care; Mentorship; Family medicine; Health care; Medical education; Economic growth","score_opus":0.19634782246600438,"score_gpt":0.5202719550405129,"score_spread":0.3239241325745086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324017998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031933763,0.99801093,0.00008313235,0.0010433022,0.00022831406,0.0000042418787,0.000009049505,0.0000042499773,0.0005847873],"genre_scores_gemma":[0.00025472566,0.99873966,0.00015297897,0.00055875414,0.00013588078,0.000004060741,0.000012750526,9.964e-7,0.00014026376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990908,0.0002939186,0.00012883627,0.000084810155,0.00032770511,0.00007400406],"domain_scores_gemma":[0.9971181,0.0019638152,0.00028540118,0.000039175564,0.00044162085,0.00015189768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023425985,0.0009342893,0.002288977,0.0020685499,0.00043612169,0.0022462392,0.0013022746,0.002096174,0.006487931],"category_scores_gemma":[0.0034984597,0.00034836572,0.0008583553,0.003230067,0.0007294807,0.00290244,0.0015983302,0.0034929116,0.0017303234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046467696,0.000048492886,0.00013216991,0.042732295,0.0001572634,0.00007937902,0.000101490616,0.0003092449,0.0003236013,0.006012017,0.034388494,0.915669],"study_design_scores_gemma":[0.000029747078,0.000058819172,0.0006527746,0.045680545,0.0002938867,0.0004530011,0.0001660452,0.00009882915,0.00009542078,0.0032244285,0.94922155,0.000025026913],"about_ca_topic_score_codex":0.0027888531,"about_ca_topic_score_gemma":0.009058778,"teacher_disagreement_score":0.006487931,"about_ca_system_score_codex":0.0016431881,"about_ca_system_score_gemma":0.0046059415,"threshold_uncertainty_score":0.021704316},"labels":[],"label_agreement":null},{"id":"W4377221133","doi":"10.1007/s11864-023-01097-w","title":"Critical Appraisal of Proton Therapy for Patients with Central Nervous System (CNS) Malignancies","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Proton therapy; Central nervous system; Radiation therapy; Disease; Surgery; Pathology; Internal medicine","score_opus":0.11612876719487061,"score_gpt":0.4503622528551682,"score_spread":0.33423348566029754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377221133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037715872,0.9992299,0.000024623725,0.00030042246,0.00015358174,0.0000039149268,0.000011690543,0.0000016974385,0.00023644808],"genre_scores_gemma":[0.00046670128,0.99857116,0.00008290421,0.00052661804,0.00020071997,0.0000064573837,0.000018900986,9.0010207e-7,0.00012570202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958533,0.0001308166,0.00009451119,0.000048954153,0.00011444813,0.000026036674],"domain_scores_gemma":[0.9987936,0.0007537563,0.00017989978,0.000016337726,0.00021440188,0.000041955773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016129668,0.0007247902,0.002059999,0.0013690947,0.00022893891,0.001084452,0.0010564473,0.001028737,0.0038905183],"category_scores_gemma":[0.0026801443,0.00028960532,0.001135397,0.0012956643,0.0004368111,0.0010790218,0.0005969006,0.0018873456,0.0007810806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036729785,0.000047720885,0.00014157272,0.09046185,0.0004978424,0.00013948554,0.00007148133,0.00034387573,0.000620004,0.0018758512,0.042546228,0.8628868],"study_design_scores_gemma":[0.00031657607,0.0004952227,0.001655202,0.06050102,0.0020871288,0.0009249446,0.00010903506,0.00019947988,0.00036732332,0.0021694666,0.93113345,0.000041239895],"about_ca_topic_score_codex":0.0016258748,"about_ca_topic_score_gemma":0.004010581,"teacher_disagreement_score":0.0038905183,"about_ca_system_score_codex":0.00092688674,"about_ca_system_score_gemma":0.0017572121,"threshold_uncertainty_score":0.013015091},"labels":[],"label_agreement":null},{"id":"W4386695406","doi":"10.1007/s11864-023-01125-9","title":"The Crying Need for a Better Response Assessment in Rectal Cancer","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Crying; Colorectal cancer; Oncology; Internal medicine; Cancer; Psychiatry","score_opus":0.30426993775718675,"score_gpt":0.5704413850166792,"score_spread":0.26617144725949243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386695406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015131437,0.97123855,0.0003054367,0.022410477,0.004463795,0.000012284215,0.00009006753,0.000017705572,0.0013103106],"genre_scores_gemma":[0.0019289545,0.97506636,0.0007033893,0.014834149,0.0059386184,0.0000297991,0.00012950141,0.000012526266,0.0013567024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992066,0.0002550658,0.0001348141,0.000090984766,0.00026978186,0.000042754542],"domain_scores_gemma":[0.9963037,0.0018832899,0.00036118648,0.00007516721,0.0012443413,0.0001323702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024998137,0.00041942456,0.0018048038,0.00095213467,0.0002203608,0.0015190367,0.0013503483,0.0026900251,0.004769275],"category_scores_gemma":[0.005360875,0.00020502448,0.00093924196,0.00090925046,0.0007452474,0.0028225968,0.00061426964,0.0041760425,0.0031741927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013685966,0.000037326998,0.00018993764,0.026932746,0.00019390798,0.0002022317,0.00007388117,0.00021722507,0.00063193345,0.0036728818,0.22053097,0.7471801],"study_design_scores_gemma":[0.00005236863,0.000082020444,0.00078938424,0.011560181,0.00019174346,0.001100422,0.00009419829,0.00012982007,0.00018394175,0.0033490297,0.98244125,0.000025699974],"about_ca_topic_score_codex":0.00078894035,"about_ca_topic_score_gemma":0.0016293903,"teacher_disagreement_score":0.004769275,"about_ca_system_score_codex":0.00059435953,"about_ca_system_score_gemma":0.0014935582,"threshold_uncertainty_score":0.015954792},"labels":[],"label_agreement":null},{"id":"W4387393214","doi":"10.1007/s11864-023-01132-w","title":"Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Durvalumab; Medicine; Atezolizumab; Pembrolizumab; Tremelimumab; Nivolumab; Ipilimumab; Oncology; Lung cancer; PD-L1; Internal medicine; Immunotherapy; Avelumab; Immune checkpoint; Blockade; Cancer; Chemotherapy; Receptor","score_opus":0.14797085779575342,"score_gpt":0.5008112849415937,"score_spread":0.35284042714584024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387393214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065439875,0.98767334,0.0031978812,0.0052618184,0.00049593067,0.000040513194,0.00010611122,0.000036552203,0.0025334563],"genre_scores_gemma":[0.012381922,0.96801066,0.011049636,0.0047076344,0.0016313149,0.00013893086,0.0004028307,0.000014754253,0.0016623312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968934,0.00009992011,0.00005607737,0.000052606316,0.000074957425,0.000027093256],"domain_scores_gemma":[0.99955267,0.00026497946,0.000063521846,0.000007388362,0.0000808885,0.00003054143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011755476,0.0006521027,0.0016143911,0.0010393056,0.0002593681,0.0013895114,0.0010159004,0.0010385563,0.002229393],"category_scores_gemma":[0.0016256828,0.00022962686,0.0009468141,0.0005194873,0.00036170366,0.0013617527,0.0005216942,0.002841049,0.0009054371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013807211,0.00007576189,0.0009807564,0.004922822,0.00016114763,0.00031750393,0.000048040998,0.0010797268,0.0009603135,0.0038388423,0.034810673,0.9526664],"study_design_scores_gemma":[0.00031575342,0.00056687725,0.006116993,0.026803665,0.0015866886,0.0055544656,0.0003565782,0.0032671504,0.0014469804,0.030000493,0.92384994,0.0001343964],"about_ca_topic_score_codex":0.000852951,"about_ca_topic_score_gemma":0.002358975,"teacher_disagreement_score":0.002229393,"about_ca_system_score_codex":0.0008309943,"about_ca_system_score_gemma":0.0015438145,"threshold_uncertainty_score":0.007458091},"labels":[],"label_agreement":null},{"id":"W4388797269","doi":"10.1007/s11864-023-01145-5","title":"The Evolving Treatment Landscape of Medullary Thyroid Cancer","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Università degli Studi di Brescia","keywords":"Medicine; Medullary cavity; Thyroid cancer; Medullary thyroid cancer; Oncology; Cancer; Thyroid; Internal medicine","score_opus":0.16793920905984108,"score_gpt":0.4785485377376829,"score_spread":0.31060932867784186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388797269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013650299,0.9933222,0.00011236668,0.0043180953,0.0009009929,0.0000035265423,0.000030080048,0.000009130665,0.0011670744],"genre_scores_gemma":[0.0010943905,0.994643,0.0001820873,0.0022714694,0.0010533963,0.0000054959337,0.00004339148,0.0000027643407,0.0007041285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997085,0.00006590877,0.00003358537,0.000047679016,0.00011479783,0.000029516676],"domain_scores_gemma":[0.9993648,0.00027048236,0.00007903257,0.00001132942,0.00023237983,0.000042032927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008511782,0.00042213243,0.0008546982,0.0010867537,0.00028441,0.0011395535,0.00081360765,0.0015540149,0.0048137917],"category_scores_gemma":[0.001329786,0.00016759535,0.00055459695,0.00094123615,0.0004502896,0.0016334101,0.000658128,0.0023521157,0.0015943138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007974685,0.000034902703,0.00017830664,0.020128505,0.00009394657,0.00028640404,0.000097249766,0.00039269924,0.0011198996,0.0056877234,0.10526119,0.86663944],"study_design_scores_gemma":[0.000015435202,0.00004938817,0.00043836693,0.005111113,0.00008153542,0.0010472328,0.000082782855,0.00009222791,0.00015871307,0.0025232902,0.99038637,0.000013496954],"about_ca_topic_score_codex":0.0014954226,"about_ca_topic_score_gemma":0.003333051,"teacher_disagreement_score":0.0048137917,"about_ca_system_score_codex":0.0010060295,"about_ca_system_score_gemma":0.0016319164,"threshold_uncertainty_score":0.016103745},"labels":[],"label_agreement":null}]}